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Abstract 
Objective To determine which service models and organisational structures are effective and cost-
effective for delivering tuberculosis services to hard-to-reach populations. 
  
Design Embase and MEDLINE (1990-2017) were searched in order to update and extend the 2011 
systematic review commissioned by NICE, discussing interventions targeting service models and 
organisational structures for the identification and management of tuberculosis in hard-to-reach 
populations. The NICE and Cochrane Collaboration standards were followed. 
 
Setting European Union, European Economic Area, European Union candidate countries and 
Organisation for Economic Co-operation and Development countries.  
 
Participants Hard-to-reach populations, including migrants, homeless people, drug users, prisoners, 
sex workers, people living with HIV and children within vulnerable and hard-to-reach populations.  
 
Primary and secondary outcome measures Effectiveness and cost-effectiveness of the interventions. 
 
Results From the 19,720 citations found, five new studies were identified, in addition to the six 
discussed in the NICE review. Community health workers from the same migrant community, street 
teams and peers improved tuberculosis screening uptake by providing health education, promoting 
tuberculosis screening and organising contact tracing. Mobile tuberculosis clinics, specialised 
tuberculosis clinics and improved cooperation between health care services can be effective at 
identifying and treating active tuberculosis cases, and ar  likely to be cost-effective. No difference in 
treatment outcome was detected when directly observed therapy was delivered at a health clinic or at a 
convenient location in the community.   
 
Conclusions Although evidence is limited due to the lack of high quality studies, interventions using 
peers and community health workers; mobile tuberculosis services, specialised tuberculosis clinics, and 
improved co-operation between health services can be effective to control tuberculosis in hard-to-reach 
populations. Future studies should evaluate the (cost-)effectiveness of interventions on TB 
identification and management in hard-to-reach populations and countries should be urged to publish 
the outcomes of their TB control systems. 
 
Systematic review registration PROSPERO CRD42015017865. 
  
Page 3 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 3
 
Introduction 
Prevention and control of tuberculosis (TB) is based on early detection and diagnosis of TB followed 
by effective treatment. In 2015 there were an estimated 10.4 million incident TB cases worldwide, an 
estimated 4.3 million cases were either not diagnosed, or diagnosed but not reported to national TB 
programmes.
1
 Trends for TB treatment are encouraging, with most notified TB cases completing their 
treatment successfully; although treatment success rates in some regions, such as the European region, 
were considerably below the WHO World Health Assembly target of 85%.1  
In many countries with a low TB incidence (less than ten TB cases per 100,000 population),
2
 TB 
prevails in the big cities where vulnerable and hard-to-reach (under-served) populations are 
concentrated.
3
 These populations, such as people who are homeless (or have insecure accommodation), 
misuse drugs or are migrants, are at higher risk of contracting TB and are more likely unable or 
unwilling to seek medical care and comply with the long term TB treatment. Managing TB in those 
populations is therefore challenging, due to barriers caused by stigma, cultural barriers, poor access to 
health care services and low levels of accurate TB knowledge.
4,5-7
 This therefore requires special 
efforts. Health care services need to be organised effectively to identify and diagnose TB cases, and to 
provide adequate treatment and support. This can be organised in different ways, e.g. mainly as 
hospital-based8 or health centre-based;9 including the public sector, private sector,10 or civil society and 
other partners.
11
 Sometimes, organisation of the services has proven ineffective in managing TB.
12
  
The review question of this systematic review with a scoping component was: ‘Which service models 
and organisational structures, including different types of healthcare workers and settings, are effective 
and cost-effective for delivering TB services to hard-to-reach populations in low- and medium-
incidence countries?’ 
Findings of this review and the previously published review series 
4,13
 formed the base for the guidance 
document by the European Centre for Disease Prevention and Control (ECDC) on controlling TB in 
hard-to-reach and vulnerable populations.14  
 
Methods 
Strengths and limitations of this study 
• PRISMA and Cochrane Collaboration reporting guidelines for systematic reviews were 
followed. 
• The search was highly sensitive but we might have missed important information as many 
European countries do not publish their tuberculosis identification and management data in 
journals, our search focused on Embase and MEDLINE. 
• We identified five studies and discuss the results together with the six studies identified by the 
NICE review to give the complete body of evidence.  
• None of the included studies was of high quality and there was high heterogeneity across the 
studies prohibiting a meta-analysis. 
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In 2011, the Matrix Knowledge Group published a review, commissioned by the National Institute for 
Health and Clinical Excellence (NICE), on effectiveness and cost-effectiveness of service models or 
structures, focussing on the type of health care worker and setting, to identify and manage TB in hard-
to-reach populations. We updated and extended the NICE review,
15
 using the same methodology but 
adjusting the focus by excluding latent TB infection and including additional hard-to-reach 
populations. The review was conducted following standards described by the Cochrane Collaboration16 
and NICE methods guidelines.
17
 Results are reported according to PRISMA guidelines.
18
 The review 
protocol was registered in advance in the database of prospectively registered systematic reviews in 
health and social care, PROSPERO (CRD42015017865).  
 
Selection of studies and data management 
The same search strategy as for the previous NICE review
15
 and the previous published review by 
Heuvelings et al.
13
 was used, searching Embase and MEDLINE through the Ovid platform. The search 
was expanded by including all European Union (EU)/European Economic Area (EEA) and EU 
candidate countries to the Organisation for Economic Co-operation and Development (OECD) 
countries (see Box 1).15 Two hard-to-reach populations (people living with HIV and children within 
vulnerable and hard-to-reach populations), were added in addition to the hard-to-reach populations 
included by the NICE review (migrants including refugees, asylum seekers and the Roma population, 
homeless people including rough sleepers and shelter users, drug users, prisoners and sex workers).15 
The update of the search conducted for the NICE review
15
 covered the period 1 January 2010 
(overlapping the end of the search period of the NICE review
15
 with a few months) to 24 February 
2017. The search for the expanded geographical area and newly included hard-to-reach populations 
covered a time period from 1 January 1990 (beginning of the search period used in the NICE review
15
) 
to 24 February 2017.  
Reference lists of relevant systematic reviews were scanned. No language restrictions were applied. 
Studies focussing on the effectiveness and/or cost-effectiveness of interventions for service models and 
organisational structures supporting TB identification and management of hard-to-reach populations 
(see Box 1) were included.  
Predefined interventions were using more convenient locations (like specialised TB centres, shelters 
for homeless people or drug users, needle exchange/methadone programme locations, port of arrival, 
schools or mobile clinics) and peers or health care workers with the same ethnic or cultural 
background; however, other interventions could also be included if they supported TB identification or 
management in hard-to-reach populations. TB identification tools, TB diagnostics, incentives, social 
support, directly observed therapy and treatment of co-morbidities are discussed in another review.
13
 In 
this review we aim to identify the effectiveness of the type of health worker and setting, to identify and 
manage TB in hard to reach and vulnerable populations.  
 
The comparator was defined during the review process;  interventions were compared to a relevant 
comparator, for example usual care or no intervention, another intervention, or historical comparison. 
Page 5 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 5
Outcomes were defined as any measure of TB identification and management (for example, number of 
people screened, screening coverage, proportion receiving treatment and treatment completion rate). 
Effectiveness was defined as an improvement in any measure of TB identification and/or management. 
Randomised and non-randomised studies were eligible for inclusion.  
See Supplementary Material I for the PROSPERO study protocol, Supplementary Material II 
for PICOS (Population-Intervention-Comparator-Outcome-Study design) questions and 
Supplementary Material III for the complete search strategy and search results. 
 
Data extraction, data items, and synthesis 
Identified citations were entered into an EndNote database, and duplicates removed (EndNote X7.1, 
Thomson Reuters 2014). The inclusion criteria were piloted and refined using the first 25 citations. 
Double screening was conducted by one reviewer screening 100% of the citations (CCH) while another 
two reviewers screened 50% of the citations each (PFG, SGdV) for inclusion on title and abstract. 
Disagreement was resolved by discussion. Full text files of included citations were retrieved; 
irretrievable articles (not available after attempts online, from the university library or through 
contacting authors) were excluded. Two reviewers assessed full text records for inclusion (CCH, PFG). 
Disagreement was resolved by discussion. Agreement after screening on title and abstract was 99.6% 
with an inter-rater reliability (Cohen’s kappa) of κ = 0.985. 
 
Data extraction forms from the NICE review
15
 were used to extract information on participant 
characteristics, settings, types of services/organisational structures, types of healthcare workers 
delivering the service, outcome measures, methods of analysis and results. For one study data 
extraction was conducted by two reviewers (CCH, PFG) independently. For the remaining studies, data 
extraction was conducted by one reviewer (CCH) and checked by a second (PFG); disagreement was 
resolved by discussion. In one case, the study author was contacted to verify data and obtain additional 
data.
19 
To facilitate comparability, data synthesis was structured in a similar way to that of the NICE review.15 
Studies were divided into those examining service models and organisational structures for TB 
identification (screening) and those examining service models and organisational structures for TB 
management (treatment and support) in hard-to-reach populations. Data were analysed narratively, and 
appropriateness of meta-analysis considered. Findings were reported as stated by the study authors. 
 
Risk of bias in individual studies and overall strength of evidence 
The modified NICE Quality Assessment Tools
17
 (based on the Graphical Appraisal Tool for 
Epidemiological studies) were used to assess quality and risk of bias of included studies. This included 
an assessment of selection of study sample, minimisation of selection bias and contamination, 
controlling confounding, outcome measurements, analytical methods and risk of bias. Two reviewers 
(CCH, PFG) assessed one study independently; the remaining studies were assessed by one reviewer 
(CCH), and checked by a second reviewer (PFG). Any disagreement was resolved by discussion. 
Studies were given a quality rating based on the quality assessment: high quality [++], medium quality 
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[+], or low quality [-]. The strength of the evidence was assessed and reported as described in the 
previous NICE review
15
 (Supplementary Material IV). 
 
 
Results 
Of the 19,720 citations identified by the literature search five studies were included in this review 
(Figure 1).
11,19-22
 These five studies are in addition to the six studies
23-28
 included in the NICE review.
15
 
The results section in this paper focuses on the evidence of the five studies identified in our updated 
review. The evidence statements (presented in Supplementary Material IV) summarise evidence 
identified in terms of consistency, quality and applicability, combining evidence from the NICE 
review15 and this update.  
 
All five studies were conducted in the EU; two in the United Kingdom (UK),
19,22
 one in Germany,
20
 
one in Portugal11 and one in Spain.21 Two studies focussed on homeless people,19,20 one on homeless 
people and drug users,
22
 one on drug users alone
11
 and one on migrants.
21
 Four studies
5,19-21
 addressed 
the influence of the type of healthcare worker on TB identification and TB management and one study 
focussed on the influence of different settings on TB identification.
22
 A variety of study designs were 
included; one study was a prospective cluster randomised controlled trial (RCT),
19
 one was an 
economic evaluation using a compartmental model of treated and untreated active TB cases22, and three 
studies were retrospective comparison studies.
11,20,21
 Study characteristics of included studies are 
described in Table 1. The data extraction forms by study are presented in Supplementary Material V. 
 
None of the included studies in this review had a low risk of bias, three studies
19,21,22
 had a medium risk 
of bias, the other two studies5,20 were assessed as having a high risk of bias (Supplementary Material 
VI). 
We did not perform a meta-analysis due to study heterogeneity. Results were synthesised narratively.
29
  
 
Main outcomes for services structures and organisational models for TB identification among hard-to-
reach populations, combined with the findings of the NICE review,
15
 are summarised in Table 2. For 
full evidence statements, see Supplementary Material IV. 
 
Three studies19-21 compared the effect of the type of healthcare worker on TB identification.  
In the UK, a cluster-randomised trial found that peer educators working together with shelter staff to 
encourage homeless people to participate in a TB screening programme using mobile X-ray units 
(MXU), did not improve screening uptake compared to encouragement by shelter staff only 
(respectively 40%, interquartile range [IQR] 25-61 versus 45%, IQR 33-55; adjusted risk ratio [aRR]  
0.98, 95% confidence interval [95% CI] 0.80 to 1.20).
19
 Control sites were not ‘naïve’ for peer 
intervention which could have caused contamination of the control sites and contributed to the negative 
finding. 
Page 7 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 7
In Germany, introduction of TB education and promotion of voluntary chest X-ray (CXR) screening at 
least once every two years by community health workers (CHWs) improved screening uptake in 
homeless people and drug users. Annual screening coverage increased from 10.0% at the beginning of 
the study period (2002-2004) to 15.0% during the middle part of the study period (2004-2006), the last 
part of the study period had a 13.4% annual screening coverage (2005-2007). Screening once every 
two years increased screening coverage from 18.0% (2002-2004) to 26.4% (2004-2006). Coverage was 
23.4% at the third and final study period (spanning 2005-2007).
20
 The authors did not test for statistical 
significance, and denominator data (the number of homeless people and drug users in the study area) 
were estimated.   
 
In Barcelona, Spain, contact tracing organised by CHWs coming from the same migrant community as 
the person diagnosed with TB, improved contact tracing among migrants to 66.2% (2003-2005) 
compared to 55.4% (2000-2002) in the period before the implementation of the intervention using 
CHWs (adjusted odds ratio [aOR] of an index case having their contacts screened before and after the 
intervention was 1.8, 95% CI 1.3 to 2.5, p<0.001).
21
 Identification and tracing of at least one contact 
was taken as appropriate contact tracing, where all contacts at risk should be traced to detect and treat 
TB transmission early. The population characteristics varied, the age and country of origin was 
different between both periods. The importance of contact tracing is to identify cases early to reduce 
transmission, the authors did not report if any of the contacts traced had active TB.  
 
Two studies
11,22
 evaluated the effect of the type of healthcare worker and the setting on TB 
identification and TB management. 
In Portugal, improved co-operation of ‘key partners’ (street teams, TB clinics, drug user support 
centres, local public health department and local hospital) for TB identification and management in 
drug users was evaluated in a before-and-after study. Representatives of all ‘key partners’ (authors’ 
term) worked on improving policies, clinic screening procedures and co-operation. Key partners were 
trained in identifying drug users in their population; and offering health promotion, notification cards, 
free transport to the TB clinic, free medical and substance abuse care, directly observed therapy (DOT) 
for active TB cases, identification of non-compliant patients and the cause of non-compliance, and 
tailor-made strategies to improve compliance. This resulted in an increase of TB screening uptake; 
from 52 drug users being screened before the intervention (2001-2003 when there was no active 
screening policy) to 465 drug users screened thereafter (2005-2007). Of all people misusing drugs 
taking-up screening, the proportion without TB symptoms increased from 41.6% to 93.5% (OR = 
21.76; 95% CI 13.03 – 36.33) indicating improved TB awareness and access to screening facilities for 
drug users. Of all drug users with active TB, the proportion identified by screening increased from 
13·4% to 61·0% (OR 10·1; 95% CI: 4.44 – 23.0). Treatment default rates decreased from 35.4% to 
10.2% (OR 0·.21, 95% CI 0.08-0.54), compared to the period before the intervention (2001-2003) 
when TB treatment was not compulsory and compliance was stimulated by TB education and 
providing information on the importance of treatment completion.
11
 Although the absolute number of 
drug users screened increased, information on the screening coverage was not available as denominator 
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data were not provided. Another limitation is that the results were not adjusted for confounding factors, 
baseline characteristics might have been different as the two cohorts were recruited over different time 
periods and participation was voluntary which may have led to selection bias. 
 
In the United Kingdom, the effectiveness and cost-effectiveness of the ‘Find and Treat’ service (raising 
awareness of TB screening and providing a mobile TB screening and treatment service) for homeless 
people and drug users was evaluated and compared to people (with a history of homelessness, 
imprisonment, drug abuse or mental health problems) self-presenting to a London TB clinic receiving 
standard TB care at the clinic.
22
 The authors estimated that 22.9% of the patients detected by the ‘Find 
and Treat’ service with the longest first symptom-to-detection time would not have self-presented plus 
35.4% were asymptomatic at time of detection and would not have self-presented, only part of the 
asymptomatic patients would self-present to a TB clinic at a later stage when symptoms would have 
developed. The ‘Find and Treat’ service had a higher treatment completion rate (67.1% versus 56.8%), 
and a lower lost to follow-up rate (2.1% versus 17.2%) compared to the control group receiving 
standard TB care at a TB clinic. The authors concluded that the ‘Find and Treat’ service was cost-
effective, when using the threshold used by NICE of £20,000 to £30,000/QALY gained, with an 
incremental cost ratio of £18,000 per QALY gained for the TB screening service and £4,100 per 
QALY gained for the TB management service. This study has a few limitations: firstly, it is a non-
randomised study, secondly the ‘Find and Treat’ service identifies extremely hard-to-reach populations 
of which some would never self-present therefore the findings could be even better in less hard-to-
reach populations, and thirdly the economical evaluation is based on a compartmental model that does 
not take secondary transmission and drug-resistance into account. 
 
Discussion 
To tackle TB and disrupt transmission in high-income, low TB incidence settings, improvement of TB 
care in hard-to-reach populations is of vital importance. In this updated review, five studies,
11,19-22
 
published between 1 January 2010 and 24 February 2017, evaluating effectiveness of services models 
and organisational structures supporting TB identification and management of hard-to-reach 
populations, were identified in addition to the six studies considering active TB
23-28
 identified by the 
NICE review.
15
 Only one study
22
 evaluated cost-effectiveness. Although the evidence from two 
reviews is limited, it highlights those interventions that are likely to be effective and those that have no 
clear evidence of being effective (Table 2). For development of the ECDC guidance document,14 a 
scientific panel compiled by ECDC carefully considered these findings. Their main suggestions for 
action were to involve CHWs or peers to improve TB screening uptake and TB treatment completion 
among homeless people20 and drug users;5,20,23 to use outreach teams to improve TB screening uptake 
and TB treatment completion among vulnerable populations;
22
 and to strengthen relationships and good 
collaboration between health care workers, peers, communities, and patients to improve treatment 
outcome among vulnerable populations.
5,20,22,23
 The updated systematic review provided evidence for 
all suggestions except for using peers to improve screening uptake. This is in contrast to an American 
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study
23
 included in the original NICE review,
15
 which showed that peers improved contact tracing and 
treatment adherence among drug users. 
 
Strengths and limitations 
PRISMA and Cochrane Collaboration reporting guidelines for systematic reviews were followed. 
Established screening protocols were used, including double screening, and the search was highly 
sensitive. The methodology from the previous NICE review
15
 was followed, in order to connect this 
update and, so, describe the full body of relevant evidence. High quality evidence is lacking. Only 
one
23
 study from the NICE review
15
 was considered to be of high quality, all other studies had some 
risk of bias (five medium risk
19,21,22,24,26
 and five high risk
11,20,25,27,28
). Therefore, only limited 
conclusions can be drawn. Most studies lacked identification and adjustment for confounding factors 
and the use of appropriate analytical methods. In addition, many studies were biased, particularly with 
regard to potential selection bias. A meta-analysis could not be performed, because of heterogeneity 
across the studies. Gaps in evidence exist; no studies focussing on children within vulnerable and hard-
to-reach populations, or on people living with HIV or sex workers were identified. Only three studies 
provided economic data; one study identified by this review,22 and two25,27 by the NICE review.15  
Our search focussed on publications in databases Embase and MEDLINE. Many European countries 
have strong organisational structures for TB identification and management, but these countries did not 
publish their data on these organisational structures in journals, which may have caused a publication 
bias. Comparing findings of the NICE review
15
 with this review comes with some limitations. For the 
NICE review only 10% of the citations were double screened,
15
 compared to 100% for this updated 
review, therefore studies conducted between 1990-2010 might have been missed. The NICE review 
focussed their recommendations on the population in th  United Kingdom,
15
 and this review focussed 
on populations in high-income, low TB incidence countries. Further methodology was identical.  
 
The evidence identified by this review and the previous NICE review
15
 along with evidence presented 
in a review series covering the barriers and facilitators of seeking TB care,6 and the effectiveness of 
interventions for TB identification and management in hard-to-reach populations,
13
 was used to 
develop the ECDC guidance on improving TB identification and management among hard-to-reach 
and vulnerable populations in Europe.
14
 ECDC recommended that implementation of the interventions 
is context-specific; it depends on the setting, target population, resources available and health-care 
systems in place. Interventions focussing on one specific hard-to-reach population might not work in 
another hard-to-reach population, therefore, the interventions have to be adapted and re-assessed per 
target population.
14
 Given the scope of this review, considering settings across Europe, findings 
presented here are potentially relevant to any low-incidence region, and are relevant to other 
institutions/governmental organisations seeking to improve service structures for TB identification and 
management among hard-to-reach populations.  
 
Characteristics of different hard-to-reach populations and their TB epidemiology vary per country and 
setting. Challenges in identification and management of TB should be identified and targeted, tailored 
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to the specific setting and hard-to-reach population. These TB interventions could be integrated within 
broader programmes targeting specific populations. A follow-up systematic review should include 
information from national public health services about their organisational structures for TB 
identification and management. National public health services are urged to regularly analyse their 
organisational structures for TB identification and management and publish this data.  
Efforts to improve quality of research on service models and organisational structures should be made, 
even though it is often challenging to perform ‘clean’, unbiased, and un-confounded trials in hard-to-
reach populations, as attrition rates are often high, and confounding factors are plentiful. This includes 
conducting (cluster) randomised controlled trials and before-and-after studies where appropriate, 
recruiting an adequate number of participants, using relevant control groups, and minimising selection 
bias. Standardised case definitions for hard-to-reach populations should be created. Feasibility, 
effectiveness, cost-effectiveness and impact of interventions should be evaluated. Mathematical 
economic models can be used to evaluate costs.
14
  
 
Conclusions 
Identification and management of TB in hard-to-reach populations is suboptimal.2 Therefore, service 
models and organisational structures to identify and manage TB in hard-to-reach populations should be 
improved and evaluated regularly.  
Our systematic review, in conjunction with the original NICE review15 provides limited evidence , due 
to the lack of high quality studies, that interventions such as using peers and CHWs; mobile TB 
services, specialised TB clinics, screening, or active case finding in non-healthcare settings, as well as 
improved co-operation between key services can help to improve TB identification and management.  
Further research should be undertaken to evaluate other effective and cost-effective ways to identify 
and manage TB in hard-to-reach populations and countries with good TB control systems are urged to 
evaluate their system and publish the data.  
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28 598 references identified through database searches  
 
150 full-text articles retrieved 
5 included studies 
 
8878 removed 
       8878 duplicates 
19 570 excluded after screening 
of title and abstract 
 
145 not included 
7 irretrievable 
12 conference abstracts 
45 systematic reviews 
81 excluded after screening on full text 
 16 included in Heuvelings et al.13 
 
65 did not meet inclusion criteria 
19 720 unique articles identified  
Figure 1. Study selection process   
For the Organisation for Economic Co-operation and Development (OECD) countries and hard-to-reach populations 
discussed in the previous NICE review,13 the study period covers 1 January 2010 to 24 February 2017 
For the newly included European Union (EU)/European Economic Area/EU candidate countries, and the newly included 
hard-to-reach populations (people living with Human Immunodeficiency Virus (HIV) and children within vulnerable and 
hard-to-reach populations, the study period covers 1 January 1990 to 24 February 2017. 
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Table 1. Characteristics of studies applying different service models and organisational structures to improve TB identification and TB management  
 
First Author 
(year) country 
Population  Aims Intervention Comparator Study design Outcome 
measure 
Quality 
score 
TB identification (studies identified by this review) 
Jit et al. 
(2011)22 
United 
Kingdom 
Homeless 
people and drug 
users 
To assess the effectiveness 
and cost-effectiveness of 
the Find and Treat service 
for diagnosing and 
managing hard-to-reach 
individuals with active TB 
in London. 
 
Period 2007-2010: Find and Treat 
service: 
- screening by MXU 
- peers raising awareness  
- treatment support 
Passive case detection and 
standard treatment at a 
London TB clinic 
Observational and 
cost-effectiveness 
study 
Identified TB 
cases, treatment 
completion, lost to 
follow-up, 
incremental costs 
from healthcare 
taxpayer 
perspective 
+ 
Duarte et al. 
(2011)11  
Portugal 
 
Drug users To evaluate the effect of an 
intervention with key 
partners (TB clinic, drug 
users support centres, 
shelters, street teams, 
public health department 
and hospital) delivering 
promotion of health-
seeking behaviour, 
eliminating potential 
barriers for TB screening 
at a chest clinic and DOT, 
on identifying TB cases 
and treatment compliance. 
Improved co-operation of key 
partners (2005-2007):  
- health education and screening 
promotion 
- improved screening procedures  
- implementation of DOT 
- free TB care and transport 
- providing medical and drug 
abuse treatment 
- active follow-up of non-
compliant patients, the key 
partners worked together to reach 
the patient, identify the cause and 
organise suitable treatment 
strategies 
Period before the 
intervention (2001-2003):  
- no active screening policy 
- referral to chest clinic after 
discharge from hospital 
- treatment not compulsory 
- information about disease 
and treatment given to 
improve compliance 
- psychosocial support  
- free TB treatment, transport 
and breakfast  
Before-after study Identified TB 
cases and 
treatment 
compliance 
- 
Goetsch et al. 
(2012)20 
Germany 
 
Homeless 
people and drug 
users 
To estimate the coverage 
of a low-threshold CXR 
screening programme for 
pulmonary TB among 
illicit drug users and 
homeless persons.  
CHWs providing TB education 
and promoting voluntary CXR 
screening 1-2x/year 
Comparing the beginning of 
the 5 year intervention period 
with the end (2002-2007) 
Retrospective 
effectiveness 
study 
Screening 
coverage 
- 
Ospina et al. 
(2012)21 
Spain 
Migrants To evaluate the 
effectiveness of an 
intervention with 
community health workers 
to improve contact tracing 
among migrants 
CHWs active follow up of cases 
and contacts, including visits of 
the cases at home, accompanying 
at outpatient appointments, 
providing counselling and 
information on treatments (2003-
2005) 
Pre-intervention period 
(2000-2002) 
Before-after study Number of 
migrants that were 
included in contact 
tracing  
+ 
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Aldridge et al. 
(2015)19 
United 
Kingdom 
 
 
Homeless 
people 
To compare TB screening 
uptake between current 
practice of encouraging 
homeless people by shelter 
staff and encouragement 
by shelter staff plus 
volunteer peer educators.  
Encouragement of TB screening 
by peers in addition to shelter 
staff 
Encouragement of TB 
screening by shelter staff 
only 
Cluster 
randomised 
controlled trial 
Screening uptake  + 
TB identification (studies identified by the previous NICE review15) 
El-Hamad et al. 
(2001)24 
Italy 
Migrants To compare the completion 
rates of screening 
procedures for TB 
infection among 
undocumented migrants at 
specialised TB units and 
non-specialised health 
clinics  
TB screening at specialised TB 
clinic 
TB screening at a general 
health service for migrants 
Prospective cohort  Screening 
completion 
+ 
Bothamley et 
al. (2002)25 
United 
Kingdom 
Migrants and 
homeless 
people 
To compare the yield and 
costs of TB screening in 
three settings: a new 
entrants‘ clinic within the 
port of arrival (POA) 
scheme; a large general 
practice; and centres for 
the homeless  
TB screening at a general practice 
(GP)  
TB screening at POA and at 
homeless centres 
Cost analysis Cost per person 
screened per case 
of TB prevented 
- 
Deruaz & 
Zellweger 
(2004)28 
Switzerland 
Migrants, 
alcohol or drug 
users, homeless 
people and 
prisoners 
Evaluation of first 
experience of the DOT 
programme for TB 
introduced in the Canton of 
Vaud in 1997 
1. Full DOT 
 
2. DOT delivered at TB clinic 
1. Partial DOT (DOT only 
first 2 months of treatment) 
 
2. DOT delivered at social 
outreach site 
Before-after study Adherence to 
treatment and 
outcome 
- 
Miller et al. 
(2006)26  
United States 
Homeless 
people and 
prisoners 
To evaluate and compare 
the efficiency of a non-
state-law-mandated TB 
screening programme for 
homeless persons with a 
state-law-mandated TB 
screening programme for 
prisoners  
Non-state-law-mandated TB 
screening programme for 
homeless persons 
State-law-mandated TB 
screening programme for 
prisoners 
Retrospective 
comparison of the 
cost and health 
impacts 
TB cases averted 
and cost 
+ 
Ricks (2008)23 
United States 
Drug users To compare the 
effectiveness of using 
peers versus ‘standard’ 
public health workers to 
coordinate TB treatment 
Enhanced case management by 
peers 
Limited case management by 
heath care professionals 
Randomised 
controlled trial 
Adherence to 
treatment 
++ 
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Mor et al. 
(2008)27  
Israel 
Migrants To examine the 
effectiveness and cost-
effectiveness of pre-
migration screening and 
post-migration screening at 
POA  
Pre-migration screening Post-migration screening Retrospective 
cohort analysis 
Active TB cases, 
time between 
migration and 
diagnosis, cost-
savings 
- 
 
 
 
List of Abbreviations  
CHW = community health worker; CXR = chest X-ray; C = comparator group; DOT = direct observed treatment; GP = general practice; I = intervention group; IRIS = 
immune reconstitution inflammatory syndrome; IVDU = intravenous drug users; MXU = mobile X-ray unit; n = number of participants; QALYs = quality adjusted life 
years; POA = port-of-arrival; RCT = randomised controlled trial; TDM = therapeutic drug monitoring; TB = tuberculosis 
 
Study quality: high quality [++], medium quality [+], or low quality [-] 
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Table 2. Effectiveness of service models and organisational structures interventions to improve TB identification and TB management  
 
Population Intervention (I) Comparator (C) Studies (first 
author, year, 
country) 
No. of participants 
   I              C 
Comparison Outcome Risk of Bias 
Homeless people  
 
 
Drug users 
Health/TB 
education and 
promotion of 
screening by street 
teams, drug users 
support centres, 
shelters and CHWs 
Beginning of the 
intervention when 
CHWs were just 
introduced  
No active screening 
policy  
Goetsch et al. 2012 
(Germany)20 
 
 
Duarte et al. 2011 
(Portugal)11 
465 125 Retrospective 
comparison over 
intervention period 
 
Retrospective before-
after comparison 
Improved annual TB screening uptake 
among homeless people and drug users 
(from 10.0% to 15.0% at the peak).20 The 
percentage of all drug users with active 
TB identified by screening increased 
from 13.4% to 61.0% (OR 10.1 [95%CI 
4·44-23·0]).11 
High2 
 
 
High3 
Homeless people TB education and 
promotion of 
screening by peers 
and shelter staff  
TB education and 
promotion of 
screening by shelter 
staff only 
Aldridge et al. 2015 
(United Kingdom)19 
 
1150 1192 Comparing 
randomised 
intervention cluster 
with comparator 
cluster 
No difference in screening uptake (I = 
40% [IQR 25-61] versus C = 45% [IQR 
33-55], aRR= 0.98 [95%CI 0.80-1.20]). 
Medium4 
Migrants Pre-migration 
screening 
Post-migration 
screening at POA 
Mor et al. 2008, 
cited in the NICE 
review (Israel)27 
162 105 Retrospective 
Intervention versus 
comparator 
comparison 
Reduced the risk of developing TB in the 
new country and was cost-effective 
(0.28% of the pre-migration versus 
0.32% of the post-migration screening 
migrants developed TB; RR 0.82 
p<0.01)). The detection period was 
shorter as well (193 days versus 487 days 
between entry and diagnosis; OR=0.72 
[95%CI 0.59-0.89] p=0.002). 
High8 
 
 
Prisoners and 
homeless people 
TB screening in a 
prison 
TB screening at a 
homeless centre 
Miller et al. 2006, 
cited in the NICE 
review (United 
States)26 
22920 822 Retrospective 
comparison of two 
cohorts 
No difference in screening uptake (94.7% 
in prison versus 95% in homeless centre 
p=0.179) but higher proportion of active 
TB cases were identified at the homeless 
centre (1.2% versus 0.03% at a prison 
setting, p<0.001) 
Medium9 
Homeless people 
and migrants 
Active case finding 
by symptom-based 
questionnaire at 
homeless centres 
Active case finding 
by symptom-based 
questionnaire at 
POA 
Bothamley et al. 
2002, cited in the 
NICE review 
(United Kingdom)25 
262 199 Cost analysis Active case finding at POA was most 
cost-effective (costs per person screened 
for every case prevented at POA £10.00, 
at homeless centre £23.00). 
High10 
 
 
Migrants Active case finding 
at a specialised TB 
clinic using 2 visits 
Active case finding 
at a general primary 
care clinic, with 
referral for CXR, 
using 3 visits 
El-Hamad et al. 
2001, cited in the 
NICE review 
(Italy)24 
749 483 Prospective 
intervention versus 
comparator 
comparison 
Improved screening completion among 
migrants (85.6% in TB clinic versus 
71.4% at primary care clinic, p = not 
reported; OR=2.57 [95%CI 1.92-3.42]).  
 
Medium5 
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Drug users 
 
 
Migrants 
Contact tracing by 
peers or CHWs 
from the same 
migrant community 
Peers versus other 
health care workers 
 
Normal practice 
before introducing 
CHWs  
Ricks 2008, cited in 
the NICE review 
(United States)23 
 
Ospina et al. 2012 
(Spain)21 
48 
 
 
388 
46 
 
 
572 
RCT 
 
 
Before-after 
comparison 
Improved contact tracing among drug 
users (75% by peers versus 47% by 
healthcare workers, p = 0.03)23 and 
migrants (from 55.4% without CHWs to 
66.2% with CHWs; aOR 1.8 [95%CI 1.3-
2.5] p<0·001).21 
Low  
 
 
Medium1 
Drug users and 
homeless people 
Mobile TB 
screening and 
treatment service at 
convenient location 
in the community 
Passive case 
detection and 
management at a TB 
clinic 
Jit et al. 2011 
(United Kingdom)22 
48 252 Prospective 
intervention versus 
comparator 
comparison plus 
economic evaluation 
Improved TB identification among 
homeless people and drug users; 
particularly in asymptomatic patients 
(35.4% extra identified) and those that 
delay seeking health care (22.2% extra 
identified). Higher treatment completion 
rate (67.1% versus 56.8%) and lower lost 
to follow-up rate (2.1% versus 17.2%). 
Both parts of the service are cost-
effective (screening = £18,000/QALY 
gained, treatment is £4,100/QALY 
gained) 
Medium6 
Drug users Enhanced case 
management by 
peers 
Limited case 
management by 
regular health care 
workers 
Ricks 2008, cited in 
the NICE review 
(United States)23 
48 46 
 
RCT  Improved treatment completion in drug 
users (85% by peers versus 61% by 
health care workers, RR=2.68 [95%CI 
1.24-5.82] p=0.01).  
Low  
Drug users DOT and active 
follow-up of non-
compliant patients 
by ‘key partners’  
Non-compulsory TB 
treatment and 
education about TB 
disease and 
treatment to 
improve compliance 
Duarte et al. 2011 
(Portugal)11 
 
465 125 Retrospective before-
after comparison 
Reduced treatment default rates (from 
35.4% to 10.2%; OR 0.21 [95%CI 0.08-
0.54]). 
High2 
Migrants, drug 
users, homeless 
people and prisoners 
DOT at a 
convenient location 
in the community 
DOT at a health 
clinic 
Deruaz & Zellweger 
2004, cited in the 
NICE review 
(Switzerland) 28 
36 18 Retrospective before-
after comparison 
No significant difference in successful 
treatment outcome, treatment completion 
and cure rate (85.2% at convenient 
location versus 92.6% at health clinic, 
p=0.67) 
High7 
 
 
List of Abbreviations 
aOR = adjusted odds ratio, aRR = adjusted risk ratio, C = comparator group, CHWs = community health workers, DOT = directly observed treatment, I = intervention 
group, IQR = interquartile range, OR = odds ratio, POA = port-of-arrival, RCT = randomised controlled trial, TB = tuberculosis, 95%CI = 95% confidence interval 
 
Footnotes Risk of Bias: 
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1 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods). Contact tracing of only one contact 
was enough to be called contact tracing, and the ultimate aim of contact tracing (increase cased detection and reduce transmission) was not analysed in this study. 
2 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods). Denominator not given therefore 
unable to calculate screening coverage. 
3 = Risk of selection bias as participation was voluntary. Not adjusted for important confounding factors (intervention and comparator group were recruited over 
different time periods). No statistical test used to show statistical significance of the findings, an estimated number was used for the denominator.    
4 = Most comparator sites were not naïve for peer intervention, no individual information of the participants was collected, the characteristics between the two groups 
might have been significantly different. 
5 = Not adjusted for difference in baseline characteristics. 
6 = Study was designed to evaluate the cost-effectiveness, no statistical test used to evaluate statistical significant findings. The ‘Find and Treat’ service identifies 
extremely hard-to-reach populations that would never self-present, the findings would underestimate the benefit of the service. The economical evaluation is based on a 
compartmental model that does not take secondary transmission and drug-resistance into account, 
7 = Risk of bias due to difference in collecting treatment adherence outcome at the health clinic a nurse recorded treatment adherence at time of visit, in the social 
outreach group a health care worker was interviewed up to 6 months after treatment completion and was asked about the treatment adherence, risk of recall bias. Not 
recorded how many people per setting received 6 months of DOT (full DOT) and how many received 2 months of DOT and 4 months of self-treatment (partial DOT), 
what was another intervention in this study. Allocation to setting was based on needs of participants what might have caused bias.   
8 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods), pre-migration group had a shorter 
follow-up period than post-migration group what may have influenced the detection of number of TB cases in the pre-migration group. 
9 = Unclear if the differences in outcome was caused by the setting or by the different methods or to differences in TB prevalence in the different populations.  
10 = TB prevalence might be different in the different populations as the costs are calculated per active case detected this is a major issue, there were only 3 active TB 
cases detected, all in the POA group. The economic perspective used was not reported and the costs of identification were not discounted. 
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Box 1: Inclusion/exclusion criteria for this review 
 
Inclusion criteria: 
• Discussing service models and organisational structures, different types of healthcare workers and settings for 
delivering TB services to hard-to-reach populations;  
• Having been conducted in any of the EU/EEA countries (only updated review), the candidate countries* (only 
updated review) and the other OECD countries**  
• Having been published in 2010 or later for the OECD countries**  
• Having been published in 1990 or later for the EU/EEA countries and the EU candidate countries* not being one of 
the OECD countries (only updated review) 
• Including data from any hard-to-reach population:  
o homeless people 
o people who abuse drugs or alcohol 
o sex workers  
o prisoners or people with a history of imprisonment 
o migrants, including vulnerable migrant populations such as asylum seekers, refugees and the Roma 
population 
o children within vulnerable and hard-to-reach populations (only updated review) 
o people living with HIV (only updated review) 
• Present quantitative empirical data  
• Being a (cost)-effectiveness study, or any other type of quantitative primary research, discussing (cost-)effectiveness 
 
Exclusion criteria: 
- Latent TB infection (only updated review) 
- Systematic review (only used for reference searching) 
 
EU/EEA = European Union, European Economic Area; OECD = Organisation for Economic Co-operation and Development; 
TB = Tuberculosis 
 
*EU candidate countries = Albania, Montenegro, Serbia, the former Yugoslav Republic of Macedonia, and Turkey 
** OECD countries = Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, the Netherlands, New Zealand, 
Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States 
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Supplementary Material  
Supplementary Material I: Original study protocol   
Supplementary Material II. PICOS 
Supplementary Material III. Search strategy  
Supplementary Material IV. Evidence statements  
Supplementary Material V. Data extraction forms  
Supplementary Material VI. Quality Assessment 
Supplementary Material VII. PRISMA checklist 
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Effectiveness of service models and organisational structures supporting tuberculosis 
identification and management in hard-to-reach populations in countries of low and medium 
tuberculosis incidence: A systematic review  
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Abstract 
Objective To determine which service models and organisational structures are effective and cost-
effective for delivering tuberculosis services to hard-to-reach populations. 
  
Design Embase and MEDLINE (1990-20017) were searched in order to update and extendt the 2011 
systematic review commissioned by NICE, discussing interventions targeting service models and 
organisational structures for the identification and management of tuberculosis in hard-to-reach 
populations. The NICE and Cochrane Collaboration standards were followed. 
 
Setting European Union, European Economic Area, European Union candidate countries and 
Organisation for Economic Co-operation and Development countries.  
 
Participants Hard-to-reach populations, including migrants, homeless people, drug users, prisoners, 
sex workers, people living with HIV and children within vulnerable and hard-to-reach populations.  
 
Primary and secondary outcome measures Effectiveness and cost-effectiveness of the interventions. 
 
Results From the 19,720 citations found, five new studies were identified, in addition to the six 
discussed in the NICE review. Community health workers from the same migrant community, street 
teams and peers improved tuberculosis screening uptake by providing health education, promoting 
tuberculosis screening and organising contact tracing. Mobile tuberculosis clinics, specialised 
tuberculosis clinics and improved cooperation between health care services can be effective at 
identifying and treating active tuberculosis cases, and ar  likely to be cost-effective. No difference in 
treatment outcome was detected when directly observed therapy was delivered at a health clinic or at a 
convenient location in the community.   
 
Conclusions Although evidence is limited due to the lack of high quality studies, interventions using 
peers and community health workers; mobile tuberculosis services, specialised tuberculosis clinics, and 
improved co-operation between health services can be effective to control tuberculosis in hard-to-reach 
populations. Future studies should evaluate the (cost-)effectiveness of interventions on TB 
identification and management in hard-to-reach populations and countries should be urged to publish 
the outcomes of their TB control systems. 
 
Systematic review registration PROSPERO CRD42015017865. 
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Introduction 
Prevention and control of tuberculosis (TB) is based on early detection and diagnosis of TB followed 
by effective treatment. In 2015 there were an estimated 10.4 million incident TB cases worldwide, an 
estimated 4.3 million cases were either not diagnosed, or diagnosed but not reported to national TB 
programmes.1 Trends for TB treatment are encouraging, with most notified TB cases completing their 
treatment successfully; although treatment success rates in some regions, such as the European region, 
were considerably below the WHO World Health Assembly target of 85%.
1
  
In many countries with a low TB incidence (less than ten TB cases per 100,000 population),2 TB 
prevails in the big cities where vulnerable and hard-to-reach (under-served) populations are 
concentrated.
3
 These populations, such as people who are homeless (or have insecure accommodation), 
misuse drugs or are migrants, are at higher risk of contracting TB and are more likely unable or 
unwilling to seek medical care and comply with the long term TB treatment. Managing TB in those 
populations is therefore challenging, due to barriers caused by stigma, cultural barriers, poor access to 
health care services and low levels of accurate TB knowledge.
4,5-7
 This therefore requires special 
efforts. Health care services need to be organised effectively to identify and diagnose TB cases, and to 
provide adequate treatment and support. This can be organised in different ways, e.g. mainly as 
hospital-based
8
 or health centre-based;
9
 including the public sector, private sector,
10
 or civil society and 
other partners.
11
 Sometimes, organisation of the services has proven ineffective in managing TB.
12
  
The review question of this systematic review with a scoping component was: ‘Which service models 
and organisational structures, including different types of healthcare workers and settings, are effective 
and cost-effective for delivering TB services to hard-to-reach populations in low- and medium-
incidence countries?’ 
Findings of this review and the previously published review series 
4,13
 formed the base for the guidance 
document by the European Centre for Disease Prevention and Control (ECDC) on controlling TB in 
hard-to-reach and vulnerable populations.
14
  
 
Methods 
Strengths and limitations of this study 
• PRISMA and Cochrane Collaboration reporting guidelines for systematic reviews were 
followed. 
• The search was highly sensitive but we might have missed important information as many 
European countries do not publish their tuberculosis identification and management data in 
journals, our search focused on Embase and MEDLINE. 
• We identified five studies and discuss the results together with the six studies identified by the 
NICE review to give the complete body of evidence.  
• None of the included studies was of high quality and there was high heterogeneity across the 
studies prohibiting a meta-analysis. 
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In 2011, the Matrix Knowledge Group published a review, commissioned by the National Institute for 
Health and Clinical Excellence (NICE), on effectiveness and cost-effectiveness of service models or 
structures, focussing on the type of health care worker and setting, to identify and manage TB in hard-
to-reach populations. We updated and extended the NICE review,
15
 using the same methodology but 
adjusting the focus by excluding latent TB infection and including additional hard-to-reach 
populations. The review was conducted following standards described by the Cochrane Collaboration16 
and NICE methods guidelines.
17
 Results are reported according to PRISMA guidelines.
18
 The review 
protocol was registered in advance in the database of prospectively registered systematic reviews in 
health and social care, PROSPERO (CRD42015017865).  
 
Selection of studies and data management 
The same search strategy as for the previous NICE review
15
 and the previous published review by 
Heuvelings et al.
13
 was used, searching Embase and MEDLINE through the Ovid platform. The search 
was expanded by including all European Union (EU)/European Economic Area (EEA) and EU 
candidate countries to the Organisation for Economic Co-operation and Development (OECD) 
countries (see Box 1).15 Two hard-to-reach populations (people living with HIV and children within 
vulnerable and hard-to-reach populations), were added in addition to the hard-to-reach populations 
included by the NICE review (migrants including refugees, asylum seekers and the Roma population, 
homeless people including rough sleepers and shelter users, drug users, prisoners and sex workers).15 
The update of the search conducted for the NICE review
15
 covered the period 1 January 2010 
(overlapping the end of the search period of the NICE review
15
 with a few months) to 24 February 
2017. The search for the expanded geographical area and newly included hard-to-reach populations 
covered a time period from 1 January 1990 (beginning of the search period used in the NICE review
15
) 
to 24 February 2017.  
Reference lists of relevant systematic reviews were scanned. No language restrictions were applied. 
Studies focussing on the effectiveness and/or cost-effectiveness of interventions for service models and 
organisational structures supporting TB identification and management of hard-to-reach populations 
(see Box 1) were included.  
Predefined interventions were using more convenient locations (like specialised TB centres, shelters 
for homeless people or drug users, needle exchange/methadone programme locations, port of arrival, 
schools or mobile clinics) and peers or health care workers with the same ethnic or cultural 
background; however, other interventions could also be included if they supported TB identification or 
management in hard-to-reach populations. TB identification tools, TB diagnostics, incentives, social 
support, directly observed therapy and treatment of co-morbidities are discussed in another review.
13
 In 
this review we aim to identify the effectiveness of the type of health worker and setting, to identify and 
manage TB in hard to reach and vulnerable populations. 
 
The comparator was defined during the review process; interventions were compared to a relevant 
comparator, for example usual care or no intervention, another intervention, or historical comparison. 
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Outcomes were defined as any measure of TB identification and management (for example, number of 
people screened, screening coverage, proportion receiving treatment and treatment completion rate). 
Effectiveness was defined as an improvement in any measure of TB identification and/or management. 
Randomised and non-randomised studies were eligible for inclusion.  
See Supplementary Material I for the PROSPERO study protocol, Supplementary Material II 
for PICOS (Population-Intervention-Comparator-Outcome-Study design) questions and 
Supplementary Material III for the complete search strategy and search results. 
 
Data extraction, data items, and synthesis 
Identified citations were entered into an EndNote database, and duplicates removed (EndNote X7.1, 
Thomson Reuters 2014). The inclusion criteria were piloted and refined using the first 25 citations. 
Double screening was conducted by one reviewer screening 100% of the citations (CCH) while another 
two reviewers screened 50% of the citations each (PFG, SGdV) for inclusion on title and abstract. 
Disagreement was resolved by discussion. Full text files of included citations were retrieved; 
irretrievable articles (not available after attempts online, from the university library or through 
contacting authors) were excluded. Two reviewers assessed full text records for inclusion (CCH, PFG). 
Disagreement was resolved by discussion. Agreement after screening on title and abstract was 99.6% 
with an inter-rater reliability (Cohen’s kappa) of κ = 0.985. 
 
Data extraction forms from the NICE review
15
 were used to extract information on participant 
characteristics, settings, types of services/organisational structures, types of healthcare workers 
delivering the service, outcome measures, methods of analysis and results. For one study data 
extraction was conducted by two reviewers (CCH, PFG) independently. For the remaining studies, data 
extraction was conducted by one reviewer (CCH) and checked by a second (PFG); disagreement was 
resolved by discussion. In one case, the study author was contacted to verify data and obtain additional 
data.
19 
To facilitate comparability, data synthesis was structured in a similar way to that of the NICE review.15 
Studies were divided into those examining service models and organisational structures for TB 
identification (screening) and those examining service models and organisational structures for TB 
management (treatment and support) in hard-to-reach populations. Data were analysed narratively, and 
appropriateness of meta-analysis considered. Findings were reported as stated by the study authors. 
 
Risk of bias in individual studies and overall strength of evidence 
The modified NICE Quality Assessment Tools
17
 (based on the Graphical Appraisal Tool for 
Epidemiological studies) were used to assess quality and risk of bias of included studies. This included 
an assessment of selection of study sample, minimisation of selection bias and contamination, 
controlling confounding, outcome measurements, analytical methods and risk of bias. Two reviewers 
(CCH, PFG) assessed one study independently; the remaining studies were assessed by one reviewer 
(CCH), and checked by a second reviewer (PFG). Any disagreement was resolved by discussion. 
Studies were given a quality rating based on the quality assessment: high quality [++], medium quality 
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[+], or low quality [-]. The strength of the evidence was assessed and reported as described in the 
previous NICE review
15
 (Supplementary Material IV). 
 
 
Results 
Of the 19,720 citations identified by the literature search five studies were included in this review 
(Figure 1).
11,19-22
 These five studies are in addition to the six studies
23-28
 included in the NICE review.
15
 
The results section in this paper focuses on the evidence of the five studies identified in our updated 
review. The evidence statements (presented in Supplementary Material IV) summarise evidence 
identified in terms of consistency, quality and applicability, combining evidence from the NICE 
review15 and this update.  
 
All five studies were conducted in the EU; two in the United Kingdom (UK),
19,22
 one in Germany,
20
 
one in Portugal11 and one in Spain.21 Two studies focussed on homeless people,19,20 one on homeless 
people and drug users,
22
 one on drug users alone
11
 and one on migrants.
21
 Four studies
5,19-21
 addressed 
the influence of the type of healthcare worker on TB identification and TB management and one study 
focussed on the influence of different settings on TB identification.
22
 A variety of study designs were 
included; one study was a prospective cluster randomised controlled trial (RCT),
19
 one was an 
economic evaluation using a compartmental model of treated and untreated active TB cases22, and three 
studies were retrospective comparison studies.
11,20,21
 Study characteristics of included studies are 
described in Table 1. The data extraction forms by study are presented in Supplementary Material V. 
 
None of the included studies in this review had a low risk of bias, three studies
19,21,22
 had a medium risk 
of bias, the other two studies5,20 were assessed as having a high risk of bias (Supplementary Material 
VI). 
We did not perform a meta-analysis due to study heterogeneity. Results were synthesised narratively.
29
  
 
Main outcomes for services structures and organisational models for TB identification among hard-to-
reach populations, combined with the findings of the NICE review,
15
 are summarised in Table 2. For 
full evidence statements, see Supplementary Material IV. 
 
Three studies19-21 compared the effect of the type of healthcare worker on TB identification.  
In the UK, a cluster-randomised trial found that peer educators working together with shelter staff to 
encourage homeless people to participate in a TB screening programme using mobile X-ray units 
(MXU), did not improve screening uptake compared to encouragement by shelter staff only 
(respectively 40%, interquartile range [IQR] 25-61 versus 45%, IQR 33-55; adjusted risk ratio [aRR]  
0.98, 95% confidence interval [95% CI] 0.80 to 1.20).
19
 Control sites were not ‘naïve’ for peer 
intervention which could have caused contamination of the control sites and contributed to the negative 
finding. 
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In Germany, introduction of TB education and promotion of voluntary chest X-ray (CXR) screening at 
least once every two years by community health workers (CHWs) improved screening uptake in 
homeless people and drug users. Annual screening coverage increased from 10.0% at the beginning of 
the study period (2002-2004) to 15.0% during the middle part of the study period (2004-2006), the last 
part of the study period had a 13.4% annual screening coverage (2005-2007). Screening once every 
two years increased screening coverage from 18.0% (2002-2004) to 26.4% (2004-2006). Coverage was 
23.4% at the third and final study period (spanning 2005-2007).
20
 The authors did not test for statistical 
significance, and denominator data (the number of homeless people and drug users in the study area) 
were estimated.   
 
In Barcelona, Spain, contact tracing organised by CHWs coming from the same migrant community as 
the person diagnosed with TB, improved contact tracing among migrants to 66.2% (2003-2005) 
compared to 55.4% (2000-2002) in the period before the implementation of the intervention using 
CHWs (adjusted odds ratio [aOR] of an index case having their contacts screened before and after the 
intervention was 1.8, 95% CI 1.3 to 2.5, p<0.001).
21
 Identification and tracing of at least one contact 
was taken as appropriate contact tracing, where all contacts at risk should be traced to detect and treat 
TB transmission early. The population characteristics varied, the age and country of origin was 
different between both periods. The importance of contact tracing is to identify cases early to reduce 
transmission, the authors did not report if any of the contacts traced had active TB.  
 
Two studies
11,22
 evaluated the effect of the type of healthcare worker and the setting on TB 
identification and TB management. 
In Portugal, improved co-operation of ‘key partners’ (street teams, TB clinics, drug user support 
centres, local public health department and local hospital) for TB identification and management in 
drug users was evaluated in a before-and-after study. Representatives of all ‘key partners’ (authors’ 
term) worked on improving policies, clinic screening procedures and co-operation. Key partners were 
trained in identifying drug users in their population; and offering health promotion, notification cards, 
free transport to the TB clinic, free medical and substance abuse care, directly observed therapy (DOT) 
for active TB cases, identification of non-compliant patients and the cause of non-compliance, and 
tailor-made strategies to improve compliance. This resulted in an increase of TB screening uptake; 
from 52 drug users being screened before the intervention (2001-2003 when there was no active 
screening policy) to 465 drug users screened thereafter (2005-2007). Of all people misusing drugs 
taking-up screening, the proportion without TB symptoms increased from 41.6% to 93.5% (OR = 
21.76; 95% CI 13.03 – 36.33) indicating improved TB awareness and access to screening facilities for 
drug users. Of all drug users with active TB, the proportion identified by screening increased from 
13·4% to 61·0% (OR 10·1; 95% CI: 4.44 – 23.0). Treatment default rates decreased from 35.4% to 
10.2% (OR 0·.21, 95% CI 0.08-0.54), compared to the period before the intervention (2001-2003) 
when TB treatment was not compulsory and compliance was stimulated by TB education and 
providing information on the importance of treatment completion.
11
 Although the absolute number of 
drug users screened increased, information on the screening coverage was not available as denominator 
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data were not provided. Another limitation is that the results were not adjusted for confounding factors, 
baseline characteristics might have been different as the two cohorts were recruited over different time 
periods and participation was voluntary which may have led to selection bias. 
 
In the United Kingdom, the effectiveness and cost-effectiveness of the ‘Find and Treat’ service (raising 
awareness of TB screening and providing a mobile TB screening and treatment service) for homeless 
people and drug users was evaluated and compared to people (with a history of homelessness, 
imprisonment, drug abuse or mental health problems) self-presenting to a London TB clinic receiving 
standard TB care at the clinic.
22
 The authors estimated that 22.9% of the patients detected by the ‘Find 
and Treat’ service with the longest first symptom-to-detection time would not have self-presented plus 
35.4% were asymptomatic at time of detection and would not have self-presented, only part of the 
asymptomatic patients would self-present to a TB clinic at a later stage when symptoms would have 
developed. The ‘Find and Treat’ service had a higher treatment completion rate (67.1% versus 56.8%), 
and a lower lost to follow-up rate (2.1% versus 17.2%) compared to the control group receiving 
standard TB care at a TB clinic. The authors concluded that the ‘Find and Treat’ service was cost-
effective, when using the threshold used by NICE of £20,000 to £30,000/QALY gained, with an 
incremental cost ratio of £18,000 per QALY gained for the TB screening service and £4,100 per 
QALY gained for the TB management service. This study has a few limitations: firstly, it is a non-
randomised study, secondly the ‘Find and Treat’ service identifies extremely hard-to-reach populations 
of which some would never self-present therefore the findings could be even better in less hard-to-
reach populations, and thirdly the economical evaluation is based on a compartmental model that does 
not take secondary transmission and drug-resistance into account. 
 
Discussion 
To tackle TB and disrupt transmission in high-income, low TB incidence settings, improvement of TB 
care in hard-to-reach populations is of vital importance. In this updated review, five studies,
11,19-22
 
published between 1 January 2010 and 24 February 2017, evaluating effectiveness of services models 
and organisational structures supporting TB identification and management of hard-to-reach 
populations, were identified in addition to the six studies considering active TB
23-28
 identified by the 
NICE review.
15
 Only one study
22
 evaluated cost-effectiveness. Although the evidence from two 
reviews is limited, it highlights those interventions that are likely to be effective and those that have no 
clear evidence of being effective (Table 2). For development of the ECDC guidance document,14 a 
scientific panel compiled by ECDC carefully considered these findings. Their main suggestions for 
action were to involve CHWs or peers to improve TB screening uptake and TB treatment completion 
among homeless people20 and drug users;5,20,23 to use outreach teams to improve TB screening uptake 
and TB treatment completion among vulnerable populations;
22
 and to strengthen relationships and good 
collaboration between health care workers, peers, communities, and patients to improve treatment 
outcome among vulnerable populations.
5,20,22,23
 The updated systematic review provided evidence for 
all suggestions except for using peers to improve screening uptake. This is in contrast to an American 
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study
23
 included in the original NICE review,
15
 which showed that peers improved contact tracing and 
treatment adherence among drug users. 
 
Strengths and limitations 
PRISMA and Cochrane Collaboration reporting guidelines for systematic reviews were followed. 
Established screening protocols were used, including double screening, and the search was highly 
sensitive. The methodology from the previous NICE review
15
 was followed, in order to connect this 
update and, so, describe the full body of relevant evidence. High quality evidence is lacking. Only 
one
23
 study from the NICE review
15
 was considered to be of high quality, all other studies had some 
risk of bias (five medium risk
19,21,22,24,26
 and five high risk
11,20,25,27,28
). Therefore, only limited 
conclusions can be drawn. Most studies lacked identification and adjustment for confounding factors 
and the use of appropriate analytical methods. In addition, many studies were biased, particularly with 
regard to potential selection bias. A meta-analysis could not be performed, because of heterogeneity 
across the studies. Gaps in evidence exist; no studies focussing on children within vulnerable and hard-
to-reach populations, or on people living with HIV or sex workers were identified. Only three studies 
provided economic data; one study identified by this review,22 and two25,27 by the NICE review.15  
Our search focussed on publications in databases Embase and MEDLINE. Many European countries 
have strong organisational structures for TB identification and management, but these countries did not 
publish their data on these organisational structures in journals, which may have caused a publication 
bias. Comparing findings of the NICE review
15
 with this review comes with some limitations. For the 
NICE review only 10% of the citations were double screened,
15
 compared to 100% for this updated 
review, therefore studies conducted between 1990-2010 might have been missed. The NICE review 
focussed their recommendations on the population in th  United Kingdom,
15
 and this review focussed 
on populations in high-income, low TB incidence countries. Further methodology was identical.  
 
The evidence identified by this review and the previous NICE review
15
 along with evidence presented 
in a review series covering the barriers and facilitators of seeking TB care,6 and the effectiveness of 
interventions for TB identification and management in hard-to-reach populations,
13
 was used to 
develop the ECDC guidance on improving TB identification and management among hard-to-reach 
and vulnerable populations in Europe.
14
 ECDC recommended that implementation of the interventions 
is context-specific; it depends on the setting, target population, resources available and health-care 
systems in place. Interventions focussing on one specific hard-to-reach population might not work in 
another hard-to-reach population, therefore, the interventions have to be adapted and re-assessed per 
target population.
14
 Given the scope of this review, considering settings across Europe, findings 
presented here are potentially relevant to any low-incidence region, and are relevant to other 
institutions/governmental organisations seeking to improve service structures for TB identification and 
management among hard-to-reach populations. 
 
 
Characteristics of different hard-to-reach populations and their TB epidemiology vary per country and 
setting. Challenges in identification and management of TB should be identified and targeted, tailored 
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to the specific setting and hard-to-reach population. These TB interventions could be integrated within 
broader programmes targeting specific populations. A follow-up systematic review should include 
information from national public health services about their organisational structures for TB 
identification and management. National public health services are urged to regularly analyse their 
organisational structures for TB identification and management and publish this data.  
Efforts to improve quality of research on service models and organisational structures should be made, 
even though it is often challenging to perform ‘clean’, unbiased, and un-confounded trials in hard-to-
reach populations, as attrition rates are often high, and confounding factors are plentiful. This includes 
conducting (cluster) randomised controlled trials and before-and-after studies where appropriate, 
recruiting an adequate number of participants, using relevant control groups, and minimising selection 
bias. Standardised case definitions for hard-to-reach populations should be created. Feasibility, 
effectiveness, cost-effectiveness and impact of interventions should be evaluated. Mathematical 
economic models can be used to evaluate costs.
14
  
 
Conclusions 
Identification and management of TB in hard-to-reach populations is suboptimal.2 Therefore, service 
models and organisational structures to identify and manage TB in hard-to-reach populations should be 
improved and evaluated regularly.  
Our systematic review, in conjunction with the original NICE review15 provides limited evidence, due 
to the lack of high quality studies, that interventions such as using peers and CHWs; mobile TB 
services, specialised TB clinics, screening, or active case finding in non-healthcare settings, as well as 
improved co-operation between key services can help to improve TB identification and management.  
Further research should be undertaken to evaluate other effective and cost-effective ways to identify 
and manage TB in hard-to-reach populations and countries with good TB control systems are urged to 
evaluate their system and publish the data.  
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28 598 references identified through database searches  
 
150 full-text articles retrieved 
5 included studies 
 
8878 removed 
       8878 duplicates 
19 570 excluded after screening 
of title and abstract 
 
145 not included 
7 irretrievable 
12 conference abstracts 
45 systematic reviews 
81 excluded after screening on full text 
 16 included in Heuvelings et al.13 
 
65 did not meet inclusion criteria 
19 720 unique articles identified  
Figure 1. Study selection process   
For the Organisation for Economic Co-operation and Development (OECD) countries and hard-to-reach populations 
discussed in the previous NICE review,13 the study period covers 1 January 2010 to 24 February 2017 
For the newly included European Union (EU)/European Economic Area/EU candidate countries, and the newly included 
hard-to-reach populations (people living with Human Immunodeficiency Virus (HIV) and children within vulnerable and 
hard-to-reach populations, the study period covers 1 January 1990 to 24 February 2017. 
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Table 1. Characteristics of studies applying different service models and organisational structures to improve TB identification and TB management  
 
First Author 
(year) country 
Population  Aims Intervention Comparator Study design Outcome 
measure 
Quality 
score 
TB identification (studies identified by this review) 
Jit et al. 
(2011)22 
United 
Kingdom 
Homeless 
people and drug 
users 
To assess the effectiveness 
and cost-effectiveness of 
the Find and Treat service 
for diagnosing and 
managing hard-to-reach 
individuals with active TB 
in London. 
 
Period 2007-2010: Find and Treat 
service: 
- screening by MXU 
- peers raising awareness  
- treatment support 
Passive case detection and 
standard treatment at a 
London TB clinic 
Observational and 
cost-effectiveness 
study 
Identified TB 
cases, treatment 
completion, lost to 
follow-up, 
incremental costs 
from healthcare 
taxpayer 
perspective 
+ 
Duarte et al. 
(2011)11  
Portugal 
 
Drug users To evaluate the effect of an 
intervention with key 
partners (TB clinic, drug 
users support centres, 
shelters, street teams, 
public health department 
and hospital) delivering 
promotion of health-
seeking behaviour, 
eliminating potential 
barriers for TB screening 
at a chest clinic and DOT, 
on identifying TB cases 
and treatment compliance. 
Improved co-operation of key 
partners (2005-2007):  
- health education and screening 
promotion 
- improved screening procedures  
- implementation of DOT 
- free TB care and transport 
- providing medical and drug 
abuse treatment 
- active follow-up of non-
compliant patients, the key 
partners worked together to reach 
the patient, identify the cause and 
organise suitable treatment 
strategies 
Period before the 
intervention (2001-2003):  
- no active screening policy 
- referral to chest clinic after 
discharge from hospital 
- treatment not compulsory 
- information about disease 
and treatment given to 
improve compliance 
- psychosocial support  
- free TB treatment, transport 
and breakfast  
Before-after study Identified TB 
cases and 
treatment 
compliance 
- 
Goetsch et al. 
(2012)20 
Germany 
 
Homeless 
people and drug 
users 
To estimate the coverage 
of a low-threshold CXR 
screening programme for 
pulmonary TB among 
illicit drug users and 
homeless persons.  
CHWs providing TB education 
and promoting voluntary CXR 
screening 1-2x/year 
Comparing the beginning of 
the 5 year intervention period 
with the end (2002-2007) 
Retrospective 
effectiveness 
study 
Screening 
coverage 
- 
Ospina et al. 
(2012)21 
Spain 
Migrants To evaluate the 
effectiveness of an 
intervention with 
community health workers 
to improve contact tracing 
among migrants 
CHWs active follow up of cases 
and contacts, including visits of 
the cases at home, accompanying 
at outpatient appointments, 
providing counselling and 
information on treatments (2003-
2005) 
Pre-intervention period 
(2000-2002) 
Before-after study Number of 
migrants that were 
included in contact 
tracing  
+ 
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Aldridge et al. 
(2015)19 
United 
Kingdom 
 
 
Homeless 
people 
To compare TB screening 
uptake between current 
practice of encouraging 
homeless people by shelter 
staff and encouragement 
by shelter staff plus 
volunteer peer educators.  
Encouragement of TB screening 
by peers in addition to shelter 
staff 
Encouragement of TB 
screening by shelter staff 
only 
Cluster 
randomised 
controlled trial 
Screening uptake  + 
TB identification (studies identified by the previous NICE review15) 
El-Hamad et al. 
(2001)24 
Italy 
Migrants To compare the completion 
rates of screening 
procedures for TB 
infection among 
undocumented migrants at 
specialised TB units and 
non-specialised health 
clinics  
TB screening at specialised TB 
clinic 
TB screening at a general 
health service for migrants 
Prospective cohort  Screening 
completion 
+ 
Bothamley et 
al. (2002)25 
United 
Kingdom 
Migrants and 
homeless 
people 
To compare the yield and 
costs of TB screening in 
three settings: a new 
entrants‘ clinic within the 
port of arrival (POA) 
scheme; a large general 
practice; and centres for 
the homeless  
TB screening at a general practice 
(GP)  
TB screening at POA and at 
homeless centres 
Cost analysis Cost per person 
screened per case 
of TB prevented 
- 
Deruaz & 
Zellweger 
(2004)28 
Switzerland 
Migrants, 
alcohol or drug 
users, homeless 
people and 
prisoners 
Evaluation of first 
experience of the DOT 
programme for TB 
introduced in the Canton of 
Vaud in 1997 
1. Full DOT 
 
2. DOT delivered at TB clinic 
1. Partial DOT (DOT only 
first 2 months of treatment) 
 
2. DOT delivered at social 
outreach site 
Before-after study Adherence to 
treatment and 
outcome 
- 
Miller et al. 
(2006)26  
United States 
Homeless 
people and 
prisoners 
To evaluate and compare 
the efficiency of a non-
state-law-mandated TB 
screening programme for 
homeless persons with a 
state-law-mandated TB 
screening programme for 
prisoners  
Non-state-law-mandated TB 
screening programme for 
homeless persons 
State-law-mandated TB 
screening programme for 
prisoners 
Retrospective 
comparison of the 
cost and health 
impacts 
TB cases averted 
and cost 
+ 
Ricks (2008)23 
United States 
Drug users To compare the 
effectiveness of using 
peers versus ‘standard’ 
public health workers to 
coordinate TB treatment 
Enhanced case management by 
peers 
Limited case management by 
heath care professionals 
Randomised 
controlled trial 
Adherence to 
treatment 
++ 
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Mor et al. 
(2008)27  
Israel 
Migrants To examine the 
effectiveness and cost-
effectiveness of pre-
migration screening and 
post-migration screening at 
POA  
Pre-migration screening Post-migration screening Retrospective 
cohort analysis 
Active TB cases, 
time between 
migration and 
diagnosis, cost-
savings 
- 
 
 
 
List of Abbreviations  
CHW = community health worker; CXR = chest X-ray; C = comparator group; DOT = direct observed treatment; GP = general practice; I = intervention group; IRIS = 
immune reconstitution inflammatory syndrome; IVDU = intravenous drug users; MXU = mobile X-ray unit; n = number of participants; QALYs = quality adjusted life 
years; POA = port-of-arrival; RCT = randomised controlled trial; TDM = therapeutic drug monitoring; TB = tuberculosis 
 
Study quality: high quality [++], medium quality [+], or low quality [-] 
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Table 2. Effectiveness of service models and organisational structures interventions to improve TB identification and TB management  
Population Intervention (I) Comparator (C) Studies (first 
author, year, 
country) 
No. of participants 
   I              C 
Comparison Outcome Risk of Bias 
Homeless people  
 
 
Drug users 
Health/TB 
education and 
promotion of 
screening by street 
teams, drug users 
support centres, 
shelters and CHWs 
Beginning of the 
intervention when 
CHWs were just 
introduced  
No active screening 
policy  
Goetsch et al. 2012 
(Germany)20 
 
 
Duarte et al. 2011 
(Portugal)11 
465 125 Retrospective 
comparison over 
intervention period 
 
Retrospective before-
after comparison 
Improved annual TB screening uptake 
among homeless people and drug users 
(from 10.0% to 15.0% at the peak).20 The 
percentage of all drug users with active 
TB identified by screening increased 
from 13.4% to 61.0% (OR 10.1 [95%CI 
4·44-23·0]).11 
High2 
 
 
High3 
Homeless people TB education and 
promotion of 
screening by peers 
and shelter staff  
TB education and 
promotion of 
screening by shelter 
staff only 
Aldridge et al. 2015 
(United Kingdom)19 
 
1150 1192 Comparing 
randomised 
intervention cluster 
with comparator 
cluster 
No difference in screening uptake (I = 
40% [IQR 25-61] versus C = 45% [IQR 
33-55], aRR= 0.98 [95%CI 0.80-1.20]). 
Medium4 
Migrants Pre-migration 
screening 
Post-migration 
screening at POA 
Mor et al. 2008, 
cited in the NICE 
review (Israel)27 
162 105 Retrospective 
Intervention versus 
comparator 
comparison 
Reduced the risk of developing TB in the 
new country and was cost-effective 
(0.28% of the pre-migration versus 
0.32% of the post-migration screening 
migrants developed TB; RR 0.82 
p<0.01)). The detection period was 
shorter as well (193 days versus 487 days 
between entry and diagnosis; OR=0.72 
[95%CI 0.59-0.89] p=0.002). 
High8 
 
 
Prisoners and 
homeless people 
TB screening in a 
prison 
TB screening at a 
homeless centre 
Miller et al. 2006, 
cited in the NICE 
review (United 
States)26 
22920 822 Retrospective 
comparison of two 
cohorts 
No difference in screening uptake (94.7% 
in prison versus 95% in homeless centre 
p=0.179) but higher proportion of active 
TB cases were identified at the homeless 
centre (1.2% versus 0.03% at a prison 
setting, p<0.001) 
Medium9 
Homeless people 
and migrants 
Active case finding 
by symptom-based 
questionnaire at 
homeless centres 
Active case finding 
by symptom-based 
questionnaire at 
POA 
Bothamley et al. 
2002, cited in the 
NICE review 
(United Kingdom)25 
262 199 Cost analysis Active case finding at POA was most 
cost-effective (costs per person screened 
for every case prevented at POA £10.00, 
at homeless centre £23.00). 
High10 
 
 
Migrants Active case finding 
at a specialised TB 
clinic using 2 visits 
Active case finding 
at a general primary 
care clinic, with 
referral for CXR, 
using 3 visits 
El-Hamad et al. 
2001, cited in the 
NICE review 
(Italy)24 
749 483 Prospective 
intervention versus 
comparator 
comparison 
Improved screening completion among 
migrants (85.6% in TB clinic versus 
71.4% at primary care clinic, p = not 
reported; OR=2.57 [95%CI 1.92-3.42]).  
 
Medium5 
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Drug users 
 
 
Migrants 
Contact tracing by 
peers or CHWs 
from the same 
migrant community 
Peers versus other 
health care workers 
 
Normal practice 
before introducing 
CHWs  
Ricks 2008, cited in 
the NICE review 
(United States)23 
 
Ospina et al. 2012 
(Spain)21 
48 
 
 
388 
46 
 
 
572 
RCT 
 
 
Before-after 
comparison 
Improved contact tracing among drug 
users (75% by peers versus 47% by 
healthcare workers, p = 0.03)23 and 
migrants (from 55.4% without CHWs to 
66.2% with CHWs; aOR 1.8 [95%CI 1.3-
2.5] p<0·001).21 
Low  
 
 
Medium1 
Drug users and 
homeless people 
Mobile TB 
screening and 
treatment service at 
convenient location 
in the community 
Passive case 
detection and 
management at a TB 
clinic 
Jit et al. 2011 
(United Kingdom)22 
48 252 Prospective 
intervention versus 
comparator 
comparison plus 
economic evaluation 
Improved TB identification among 
homeless people and drug users; 
particularly in asymptomatic patients 
(35.4% extra identified) and those that 
delay seeking health care (22.2% extra 
identified). Higher treatment completion 
rate (67.1% versus 56.8%) and lower lost 
to follow-up rate (2.1% versus 17.2%). 
Both parts of the service are cost-
effective (screening = £18,000/QALY 
gained, treatment is £4,100/QALY 
gained) 
Medium6 
Drug users Enhanced case 
management by 
peers 
Limited case 
management by 
regular health care 
workers 
Ricks 2008, cited in 
the NICE review 
(United States)23 
48 46 
 
RCT  Improved treatment completion in drug 
users (85% by peers versus 61% by 
health care workers, RR=2.68 [95%CI 
1.24-5.82] p=0.01).  
Low  
Drug users DOT and active 
follow-up of non-
compliant patients 
by ‘key partners’  
Non-compulsory TB 
treatment and 
education about TB 
disease and 
treatment to 
improve compliance 
Duarte et al. 2011 
(Portugal)11 
 
465 125 Retrospective before-
after comparison 
Reduced treatment default rates (from 
35.4% to 10.2%; OR 0.21 [95%CI 0.08-
0.54]). 
High2 
Migrants, drug 
users, homeless 
people and prisoners 
DOT at a 
convenient location 
in the community 
DOT at a health 
clinic 
Deruaz & Zellweger 
2004, cited in the 
NICE review 
(Switzerland) 28 
36 18 Retrospective before-
after comparison 
No significant difference in successful 
treatment outcome, treatment completion 
and cure rate (85.2% at convenient 
location versus 92.6% at health clinic, 
p=0.67) 
High7 
 
 
List of Abbreviations 
aOR = adjusted odds ratio, aRR = adjusted risk ratio, C = comparator group, CHWs = community health workers, DOT = directly observed treatment, I = intervention 
group, IQR = interquartile range, OR = odds ratio, POA = port-of-arrival, RCT = randomised controlled trial, TB = tuberculosis, 95%CI = 95% confidence interval 
 
Footnotes Risk of Bias: 
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1 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods). Contact tracing of only one contact 
was enough to be called contact tracing, and the ultimate aim of contact tracing (increase cased detection and reduce transmission) was not analysed in this study. 
2 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods). Denominator not given therefore 
unable to calculate screening coverage. 
3 = Risk of selection bias as participation was voluntary. Not adjusted for important confounding factors (intervention and comparator group were recruited over 
different time periods). No statistical test used to show statistical significance of the findings, an estimated number was used for the denominator.    
4 = Most comparator sites were not naïve for peer intervention, no individual information of the participants was collected, the characteristics between the two groups 
might have been significantly different. 
5 = Not adjusted for difference in baseline characteristics. 
6 = Study was designed to evaluate the cost-effectiveness, no statistical test used to evaluate statistical significant findings. The ‘Find and Treat’ service identifies 
extremely hard-to-reach populations that would never self-present, the findings would underestimate the benefit of the service. The economical evaluation is based on a 
compartmental model that does not take secondary transmission and drug-resistance into account, 
7 = Risk of bias due to difference in collecting treatment adherence outcome at the health clinic a nurse recorded treatment adherence at time of visit, in the social 
outreach group a health care worker was interviewed up to 6 months after treatment completion and was asked about the treatment adherence, risk of recall bias. Not 
recorded how many people per setting received 6 months of DOT (full DOT) and how many received 2 months of DOT and 4 months of self-treatment (partial DOT), 
what was another intervention in this study. Allocation to setting was based on needs of participants what might have caused bias.   
8 = Not adjusted for important confounding factors (intervention and comparator group were recruited over different time periods), pre-migration group had a shorter 
follow-up period than post-migration group what may have influenced the detection of number of TB cases in the pre-migration group. 
9 = Unclear if the differences in outcome was caused by the setting or by the different methods or to differences in TB prevalence in the different populations.  
10 = TB prevalence might be different in the different populations as the costs are calculated per active case detected this is a major issue, there were only 3 active TB 
cases detected, all in the POA group. The economic perspective used was not reported and the costs of identification were not discounted. 
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Box 1: Inclusion/exclusion criteria for this review 
 
Inclusion criteria: 
• Discussing service models and organisational structures, different types of healthcare workers and settings for 
delivering TB services to hard-to-reach populations;  
• Having been conducted in any of the EU/EEA countries (only updated review), the candidate countries* (only 
updated review) and the other OECD countries**  
• Having been published in 2010 or later for the OECD countries**  
• Having been published in 1990 or later for the EU/EEA countries and the EU candidate countries* not being one of 
the OECD countries (only updated review) 
• Including data from any hard-to-reach population:  
o homeless people 
o people who abuse drugs or alcohol 
o sex workers  
o prisoners or people with a history of imprisonment 
o migrants, including vulnerable migrant populations such as asylum seekers, refugees and the Roma 
population 
o children within vulnerable and hard-to-reach populations (only updated review) 
o people living with HIV (only updated review) 
• Present quantitative empirical data  
• Being a (cost)-effectiveness study, or any other type of quantitative primary research, discussing (cost-)effectiveness  
 
Exclusion criteria: 
- Latent TB infection (only updated review) 
- Systematic review (only used for reference searching) 
 
EU/EEA = European Union, European Economic Area; OECD = Organisation for Economic Co-operation and Development; 
TB = Tuberculosis 
 
*EU candidate countries = Albania, Montenegro, Serbia, the former Yugoslav Republic of Macedonia, and Turkey 
** OECD countries = Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, the Netherlands, New Zealand, 
Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States 
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Supplementary Material  
Supplementary Material I: Original study protocol   
Supplementary Material II. PICOS 
Supplementary Material III. Search strategy  
Supplementary Material IV. Evidence statements  
Supplementary Material V. Data extraction forms  
Supplementary Material VI. Quality Assessment 
Supplementary Material VII. PRISMA checklist 
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 PROSPERO International prospective register of systematic reviews
 
Evidence review of the effectiveness and cost effectiveness of service models or
structures aiming to manage tuberculosis in hard-to-reach groups, including a
qualitative description of these service models or structures
Charlotte Heuvelings, Sophia de Vries, Patrick Greve, Benjamin Jelle Visser, Saskia Janssen, Sabine Belard, Lianne Cremers,
Rene Spijker, Martin Grobusch
 
 Citation
Charlotte Heuvelings, Sophia de Vries, Patrick Greve, Benjamin Jelle Visser, Saskia Janssen, Sabine Belard, Lianne
Cremers, Rene Spijker, Martin Grobusch. Evidence review of the effectiveness and cost effectiveness of service
models or structures aiming to manage tuberculosis in hard-to-reach groups, including a qualitative description of
these service models or structures. PROSPERO 2015:CRD42015017865 Available from  
http://www.crd.york.ac.uk/PROSPERO_REBRANDING/display_record.asp?ID=CRD42015017865  
Review question(s)
Which service models and service structures are most effective and cost-effective at supporting TB identification and
management of hard-to-reach groups? How can these service models and organisational structures be qualitatively
described?
The following service structures will be explored:
• Type of healthcare worker (any person who was used to deliver the intervention) used to identify and manage TB in
hard-to-reach groups.
• Setting used to identify and manage TB in hard-to-reach groups.
Who is responsible for the commissioning and delivery of TB services?
What (if any) theories or conceptual models underpin the service models/organisational structures?
What specific individuals or populations are targeted by the interventions?
How does engagement in various service models/organisational structures differ by group/subgroup (in terms of hard-
to-reach group, age, or gender)?
Searches
Data Bases Health:
• EMBASE
• MEDLINE
• MEDLINE In-Process
Search terms 
1. ‘tuberculosis / TBC/ TB’ 2. ‘hard to reach groups /
population / people’ 3. ‘vulnerable groups / population / people / poor / poverty / overcrowded / excluded populations’
4. ‘homeless / hostels / shelters / poor / poverty’ 5. ‘drug* / substance* use* / abuse* / addict* / dependent / problem*
/
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disorder*’ 6. ‘Alcohol* use* / abuse* / problem* / addict*’ 7. ‘sex-worker / prostitute* / transactional sex’ 8. ‘prison* /
inmate / detaine* / detention / jail / imprisonment’ 9. ‘*migrant* / illegal / Roma* / gips* / gyps* / international
student /
expat*’ 10. ‘child*’ 11. ‘HIV / AIDS co-infection’ 12. ‘RCT / *Controlled Trial’ 13. ‘Cohort stud*’ 14. ‘*review*’ 15.
‘*report*’ 16. ‘Case stud* / report*’ 17. ‘intervention*’ 18. ‘case finding (active or passive)’ 19. ‘case management /
strategy / polic*’ 20. ‘prevention’ 21. ‘control’ 22. ‘management’ 23. ‘treat*’ 24. ‘Service model* / delivery / health
care
service* / urban health service*’ 25. ‘General practice / physician / GP / family practice / nurse lead’ 26. ‘Social
work* /
outreach / volunteer*’ 27. ‘Rehab* centre / pharmacy / ambulatory care / mobile clinic’ 28. ‘DOTS / directly observed
therapy / adherence / patient compliance’ 29. ‘Telemedicine / telephone medicine’ 30. ‘Incentives / support’ 31.
‘Screening / counselling’ 32. ‘Chest X-ray/ radiography / CXR / diagnostic test / Mantoux / skin test / TST /
GeneXpert
/ sputum smear / culture’ 33. ‘Health education / promotion’ 34. ‘Service provider’ 35. ‘Provider initiated / voluntary /
patient initiated’
We will conduct five separate search strategies; the first two search strategies (one qualitative and one quantitative
search) will be exactly the same searches as performed for the evidence reviews for the NICE guidelines. For these
OECD countries, the searches will span from August 2010 till present (December 2014, with an update performed in
the last contract month), without language barriers.
Types of study to be included
(cost-)effectiveness study, or any other type of quantitative/qualitative primary research, or a systematic
Condition or domain being studied
Tuberculosis public health interventions
Participants/ population
Hard to reach groups in European Union and OECD, like (illegal) migrants, sex workers, homeless, substance
abusers, prisoners, HIV positive people and the children of these groups
Intervention(s), exposure(s)
The reviews aim to collect evidence on all areas of interventions and service models related to identification and
management of TB in vulnerable and hard-to-reach populations, as defined in the systematic reviews by NICE. 
- Improve coverage and uptake of screening and active case finding by:
• using more convenient locations (like specialised TB clinic, centres for the homeless, large general practise, port of
arrival, schools, syringe exchange programmes, mobile clinic)
• using peers or staff from the same hard to reach group (as case managers or health advisors) 
• using small monetary incentives or food vouchers
• identifying more members of hard to reach groups
- IPT combined with methadone treatment for drug users
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- Directly Observed Therapy (DOT(S)) by peers and in more convenient locations
- Family based DOT(S) programme
- Legal detention to manage active TB
- Social care support 
- Enhanced case management 
- Directly Observed Preventive Therapy (DOPT) plus incentives
Additionally, we aim at considering the following additional interventions: 
- General interventions to improve the situation for the vulnerable and socially disadvantaged groups, e.g. provision
of housing, nutritional programmes, addressing challenges related to immigration from high-TB burden countries,
addressing inequalities and socioeconomic deprivation
- Case finding, contact tracing and screening programmes, by classic or innovative interventions for active case
finding to reduce delays in case detection and limit further transmission
- Case holding and treatment interventions to maximise treatment initiation, adherence and completion
- Use of peer support, incentives, and other means to increase effectiveness of any interventions aimed at case
finding, case holding or case management 
- The existence of programs aimed collaborations with, or interventions aimed at, alternative, traditional, and / or
spiritual medicine in TB treatment. This could be a problem that could be an obstacle in the control in TB in mainly
immigrants and asylum seekers originating from non-western countries 
- Programmes aimed at detection of patients from vulnerable or hard-to-reach populations who were lost to follow-up
will be included as well. 
- Treat comorbidities including HIV, diabetes, hepatitis, substance use disorders
- Continuity of care in the public sector for prisoners released from prison
- Improve living conditions and nutrition for prisoners
- General policies, health system organisation and structure of services that are aiming at enhancing access of care of
specific targeted vulnerable groups, to make health care (including TB services) less hard to reach for these
individuals
As this is a follow-up on the review done by NICE the following inclusion criteria will be used:
• Have a focus on TB services of any kind; 
• Are conducted in any of the EU/EEA countries, the 5 candidate countries and the other OECD countries  
• Are published in 2010 or later for the OECD countries; 
• Are published in 1990 or later for the EU/EEA countries and the 5 candidate countries;
• Include data from any hard-to-reach group 
• Present qualitative and/or quantitative empirical data; 
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• Discuss an intervention relating to one of the following: identifying TB cases; managing TB cases; design of service
models, and:
• is a (cost)-effectiveness study, or any other type of quantitative primary research, or a systematic review. 
Studies focussing on the detection and management of latent TB infection are not in the scope of this review.
Comparator(s)/ control
Not relevant
Context
The research needs to take place in an EU or OECD country and focus on any of the earlier mentioned hard to reach
groups
Outcome(s)
Primary outcomes
The most (cost-)effective service models and service structures at supporting TB identification and management of
hard-to-reach groups
Secondary outcomes
Who are responsible for putting these service structures in place and organise them.
Data extraction, (selection and coding)
Following PRISMA guidelines, study selection will be performed by two separate review authors. Three authors will
screen titles and abstracts independently in parallel for matching our research objectives. Consequently, full versions
of potentially relevant articles will be retrieved to assess eligibility. All full-text articles will be double screened. Data
will be collected from each publication and captured using the data extraction forms, according to the type of study.
Data will be extracted from text, tables and figures. The data extraction forms will be completed independently by
two review authors for a randomly selected sample of 10% of records. For the other records, the tool will be
completed by one reviewer and checked by another, with any disagreements resolved by discussion or consultation of
a senior study investigator.
Risk of bias (quality) assessment
In concordance with PRISMA guidelines and the NICE guidance document, methodological quality and risk of bias
will be assessed separately for each eligible study. Two review authors will pilot-test the tool independently on five
randomly selected studies. Quality assessments will be performed independently by two review authors for 10% of
the included studies, for the remaining 90% of the records the tool will be completed by one reviewer and checked by
another, disagreements will be resolved by discussion or consulting the third review author.
Strategy for data synthesis
We will decide to perform a meta-analysis according to the quality assessment scores and risk of bias assessments. If
studies do not support meta-analysis, data will be synthesized narratively. Overall strength of the evidence will be
assessed and reported in an additional file. Strength analysis will be performed by the reviewer who performed the
data extraction and quality assessment for the respective studies.
Analysis of subgroups or subsets
Every subgroup will be analysed separately (see previous answer)
Contact details for further information
Charlotte Heuvelings
Baljuwplein 29-II
3033 XB Rotterdam
The Netherlands
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lotjeh@hotmail.com
Organisational affiliation of the review
Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine,
Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands
www.amc.nl
Review team
Dr Charlotte Heuvelings, AMC
Dr Sophia de Vries, AMC
Dr Patrick Greve, AMC
Dr Benjamin Jelle Visser, AMC
Dr Saskia Janssen, AMC
Dr Sabine Belard, AMC
Miss Lianne Cremers, AMC
Mr Rene Spijker, AMC
Professor Martin Grobusch, AMC
Collaborators
Mr Andreas Sandgren, ECDC
Details of any existing review of the same topic by the same authors
Not by the same authors but this review is a follow up of:
Identifying and managing tuberculosis among hard-to-reach groups. Public health guidance, PH37 - Issued:
March 2012. NICE – National Institute for Health and Care Excellence. Available at:
http://guidance.nice.org.uk/PH37
Anticipated or actual start date
15 December 2014
Anticipated completion date
01 June 2015
Funding sources/sponsors
European Centre of Disease Prevention and Control
Conflicts of interest
None known
Language
English
Country
Netherlands, Sweden
Subject index terms status
Subject indexing assigned by CRD
Subject index terms
Cost-Benefit Analysis; Disease Management; Humans; Tuberculosis
Stage of review
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Completed and published
Date of registration in PROSPERO
24 March 2015
Date of publication of this revision
11 April 2017
Details of final report/publication(s)
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of
low and medium tuberculosis incidence: a systematic review
Heuvelings, Charlotte C et al.
The Lancet Infectious Diseases , 2017, http://dx.doi.org/10.1016/S1473-3099(16)30532-1.
http://thelancet.com/journals/laninf/article/PIIS1473-3099(16)30532-1/fulltext
DOI
10.15124/CRD42015017865
Stage of review at time of this submission Started Completed
Preliminary searches Yes   Yes 
Piloting of the study selection process   Yes   Yes 
Formal screening of search results against eligibility criteria   Yes   Yes 
Data extraction   Yes   Yes 
Risk of bias (quality) assessment   Yes   Yes 
Data analysis   Yes   Yes 
 
PROSPERO
International prospective register of systematic reviews
The information in this record has been provided by the named contact for this review. CRD has accepted this information in good
faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record,
any associated files or external websites.
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Supplementary Material II: PICOS (Population – Intervention – Comparator – Outcome – Study design) 
 
1. Review question 
Which service models and organisational structures, including different types of healthcare workers and 
settings, are effective and cost-effective for delivering TB services to hard-to-reach populations? 
 
2. PICOS 
Population 
Hard-to-reach groups in low incidence countries, like: 
- homeless people including rough sleepers and shelter users 
- people who abuse drugs or alcohol  
- sex workers 
- prisoners or people with a history of imprisonment 
- migrants, including vulnerable migrant populations such as asylum seekers, refugees and the 
Roma population 
- children within vulnerable and hard-to-reach populations 
- people living with HIV 
 
Studies focusing on hard-to-reach populations f om Organisation for Economic Co-operation and Development 
(OECD) countries, European Union, European Economic Area (EU/EEA) countries and the EU candidate 
countries were included.  
  
EU/EEA and candidate countries    OECD countries 
1. Albania      1. Australia 
2. Austria      2. Austria 
3. Belgium      3. Belgium 
4. Bulgaria      4. Canada 
5. Croatia      5. Chile 
6. Cyprus      6. Czech Republic 
7. Czech Republic     7. Denmark 
8. Denmark      8. Estonia 
9. Estonia      9. Finland 
10. Finland      10. France 
11. France      11. Germany 
12. Germany      12. Greece 
13. Greece      13. Hungary 
14. Hungary      14. Iceland 
15. Iceland      15. Ireland 
16. Ireland      16. Israel 
17. Italy       17. Italy 
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18. Latvia      18. Japan 
19. Liechtenstein      19. Korea 
20. Lithuania      20 Luxembourg 
21. Luxembourg      21. Mexico 
22. Malta      22. Netherlands 
23. Montenegro      23. New Zealand 
24. Netherlands      24. Norway 
25. Norway      25. Poland 
26. Poland      26. Portugal 
27. Portugal      27. Slovak Republic 
28. Romania      28. Slovenia 
29. Serbia      29. Spain 
30. Slovakia      30. Sweden 
31. Slovenia      31. Switzerland 
32. Spain      32. Turkey 
33. Sweden      33. United Kingdom 
34. The former Yugoslav Republic of Macedonia  34. United States 
35. Turkey 
36. United Kingdom  
 
Studies that did not specifically look at any of these target populations or were conducted in a different 
geographical area were excluded. 
 
Intervention 
This review aimed to collect evidence on all areas of interventions targeting service structures and service 
models for the identification and management of TB in vulnerable and hard-to-reach populations. These 
interventions can cover activities to improve TB services for screening, active case finding or TB management. 
Predefined interventions included in the protocol were: 
- Using different locations like: 
• Hospitals 
• Specialised TB clinics 
• Shelters for homeless people 
• Needle/syringe exchange programmes 
• Locations that combine care: providing treatment for drug addiction, medical care, HIV care 
• Large general practises 
• Port of arrival 
• Schools 
• Mobile clinics  
• Prisons 
- Using different type of health care workers like: 
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• Doctors 
• Nurses 
• Community health workers 
• Peers  
• People from the same background   
- Others 
• Family based DOTS programs 
• Social care support and general interventions 
o Provision of housing 
o Nutritional programmes 
o Addressing challenges related to immigration from high-TB burden countries 
o Addressing inequalities and socioeconomic deprivation 
• Collaboration with alternative, traditional, and / or spiritual medicine  
 
 
Comparator 
Not relevant. 
The comparator was re-defined during the review process into:  
Standard care.  
 
Outcome 
The outcome measures were quantitative outcomes focusing on the effectiveness and/or cost-effectiveness of 
service structures and service models aiming to identify and manage TB in hard-to-reach populations in low 
incidence countries, including a qualitative description of these interventions.  
 
Study design 
Randomised controlled trials (RCTs) focusing on service models and organisational structures on the selected 
hard-to-reach populations were included. Since it was very likely that few RCTs would be identified, we also 
included non-randomised studies like, but not exclusively, case-control studies, cohort studies, cross-sectional 
studies and observational studies. Quantitative and qualitative studies were included. Systematic reviews were 
included for reference checking only. 
 
 
3. Further notes on PICOS 
For this systematic review of interventions with a scoping component, a very broad and sensitive search was 
conducted to cover a wide range of interventions. Predefined interventions were included in our registered 
protocol but the list of interventions was not exclusive and interventions were added to the list during the review 
process. Supplementary Material I reflects the registered protocol. Changes made during the implementation of 
the systematic review protocol are stated at the end of each section. 
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Supplementary Material III: Search strategies  
The previous NICE review1 on the same topic was used as a framework for the search strategy and 
extended to the non-Organisation for Economic Co-operation and Development (OECD), countries of 
the European Union and European Economic Area and to the two newly included hard-to-reach groups 
(people living with HIV co-infected with TB and children within vulnerable and hard-to-reach 
populations). The search for the NICE review1 was subtracted from our search to prevent double 
screening of records. The search was conducted by René Spijker, clinical librarian at the Academic 
Medical Center in Amsterdam, the Netherlands. All studies identified by the search were imported to 
an Endnote database. The original search was done on the 10th of December 2014 and updated on the 
10th of April 2015 and 24th of February 2017. 
The following two databases were used for the search: 
- MEDLINE(R) In-Process & Other Non-Indexed Citations (OvidSP) 
- Embase Classic + Embase  
 
Database Hits 
Medline + Medline In-Process 12,519 
Embase 16,079 
Total 19,720 
 
References: 
1.    Rizzo M, Martin A, Jamal F, et al. Evidence review on the effectiveness and cost-effectiveness of 
service models or structures to manage tuberculosis in hard-to-reach groups. London: Matrix 
evidence/National Institute for Health and Clinical Excellence 2011. https://www.nice.org.uk/guidance 
/PH37/ documents/review-4-evidence-review-on-the-effectiveness-and-cost-effectiveness-of-service-
models-or-structures-to-manage-tuberculosis-in-hardtoreach-groups-2 (last assessed March 2017). 
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1. Search in Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) 1946 to Present 
 
Hits: 12,519 
1 exp *tuberculosis/ or (tuberculosis or tb).ti,ab. 
2 
((hard$ adj2 reach) or (hard$ adj2 locate) or (hard$ adj2 find) or (hard$ adj2 treat) or 
(difficult adj2 locate) or (difficult adj2 engage) or social$ exclu$ or social inequalit$ or 
(difficult$ adj2 reach) or (difficult$ adj2 find) or (difficult$ adj2 treat) or (christian* or 
church* or chapel* or priest* or vicar* or catholic* or catholicism or protestant* or 
methodist* or baptist* or Jehovah* or presbyterian* or anglican* or pentecostal*) or 
(muslim* or islam* or mosque* or imam*)).ti,ab. or exp *Jew/ or (jew* or judaism* or 
synagogue*).ti,ab. or exp *religion/ or (christian* or church* or chapel* or priest* or vicar* 
or catholic* or catholicism or protestant* or methodist* or baptist* or Jehovah* or 
presbyterian* or anglican* or pentecostal*).ti,ab. or (jew* or judaism* or synagogue*).ti,ab. 
or (sikh* or hindu* or buddhis* or temple*).ti,ab. or ((religion* or religious* or faith*) and 
(people* or person* or group* or population or neighbour* or neighbor* or patient* or 
communit*)).ti,ab. 
3 ((geograph$ or transport$ or physical) and barrier$).ti,ab. 
4 ((low$ or poor$ or negative) and (quality adj2 life)).ti,ab. 
5 
((vulnerable or disadvantaged or at risk or high risk or low socioeconomic status or neglect$ 
or affected or marginal$ or forgotten or non-associative or unengaged or hidden or excluded 
or transient or inaccessible or underserved or stigma$ or inequitable) and (people or 
population$ or communit$ or neighbourhood$1 or neighborhood$1 or group$ or area$1 or 
demograph$ or patient$ or social$)).ti,ab. or exp *vulnerable population/ 
6 *poverty/ 
7 
(refuser$1 or nonuser$1 or non-user$1 or non user$1 or discriminat$ or shame or prejud$ or 
racism or racial discriminat$).ti,ab. 
8 
*social support/ or exp *social status/ or *social stigma/ or exp *social isolation/ or exp 
*"quality of life"/ or exp *prejudice/ or exp *socioeconomics/ 
9 prisoner$1.ti,ab. 
10 
(recent$ adj2 release$ adj2 (inmate$ or prison$ or detainee$ or felon$ or offender$ or 
convict$ or custod$ or detention or incarcerat$ or correctional or jail$ or penitentiar$)).ti,ab. 
11 
((prison$ or penal or penitentiar$ or correctional facilit$ or jail$ or detention centre$ or 
detention center$) and (guard$1 or population or inmate$ or system$ or remand or 
detainee$ or felon$ or offender$1 or convict$ or abscond$)).ti,ab. 
12 (parole or probation).ti,ab. 
13 exp *prisoner/ 
14 ((custodial adj (care or sentence)) or (incarceration or incarcerated or imprisonment)).ti,ab. 
15 
(immobile or (disabled and (house bound or home bound)) or ((house or home) adj3 
bound)).ti,ab. or exp *homebound patient/ 
16 
((hous$ and (quality or damp$ or standard$ or afford$ or condition$ or dilapidat$)) or 
((emergency or temporary or inadequate or poor$ or overcrowd$ or over-crowd$ or over-
subscribed) and (hous$ or accommodation or shelter$ or hostel$ or dwelling$))).ti,ab. or 
exp *housing/ 
17 
(rough sleep$ or runaway$1 or ((homeless$ or street or destitut$) and (population or 
person$1 or people or group$ or individual$1 or shelter$ or hostel$ or 
accommodation$1))).ti,ab. or exp *homelessness/ 
18 
((drug$ or substance) and (illegal or misus$ or abuse or intravenous or IV or problem use$ 
or illicit use$ or addict$ or dependen$ or dependant or delinquency)).ti,ab. or exp 
*addiction/ 
19 
((alcohol$ and (misus$ or abuse or problem$ use$ or problem drink$ or illicit use$ or 
addict$ or dependen$ or delinquency)) or alcoholic$1).ti,ab. 
20 (prostitution or sex work$ or transactional sex$ or prostitute$1).ti,ab. or Prostitution/ 
21 (poverty or deprivation or financial hardship$).ti,ab. 
22 
((low-income or low income or low pay or low paid or poor or deprived or debt$ or arrear$) 
and (people or person$1 or population$1 or communit$ or group$ or social group$ or 
neighbourhood$1 or neighborhood$1 or famil$)).ti,ab. or exp *lowest income group/ 
23 *poverty/ 
24 (low$ and social class$).ti,ab. 
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25 (traveller$1 or gypsies or gypsy or Romany or roma).ti,ab. or exp *"Romani (people)"/ 
26 (mental$ and (health or ill or illness)).ti,ab. or *mental patient/ or exp *mental health/ 
27 
(health care worker$1 or (health care adj2 service provi$) or (health-care adj2 provi$) or 
(((community adj1 leader$) or (community adj1 (Manag$ or advocat$ or champion$))) and 
(engag$ or involv$))).ti,ab. 
28 (complex adj2 (patient$ or Need$)).ti,ab. 
29 (outreach adj2 worker$1).ti,ab. or exp *health auxiliary/ 
30 (support adj2 worker$1).ti,ab. 
31 (case adj2 worker$1).ti,ab. 
32 (social adj2 worker$1).ti,ab. 
33 social care professional$1.ti,ab. 
34 ((social care adj2 service provi$) or (social-care adj2 provi$)).ti,ab. 
35 
(((language$ or communicat$) and (barrier$ or understand$ or strateg$ or proficien$)) or 
translat$ or interpret$ or (cultur$ and competen$)).ti,ab. or *language ability/ 
36 
(immigrant$ or migrant$ or asylum or refugee$ or undocumented or foreign born or (born 
adj overseas) or (displaced and (people or person$1))).ti,ab. or exp *refugee/ 
37 exp *migrant/ 
38 *immigration/ 
39 or/2-38 
40 Intervention$.ti,ab. or exp *crisis intervention/ 
41 ((early or primary) adj2 Intervention$).ti,ab. 
42 
((person$ or individual or local$ or community or cultural or structural or supported or 
indicated or target$ or multi?component or comprehensive or pilot or media) and 
Intervention$).ti,ab. 
43 ((midstream or mid-stream) and intervention$).ti,ab. 
44 
(Identify$ or find or finding or locat$ or trac$ or contact$ or discover$ or detect or recruit$ 
or attract$).ti,ab. 
45 (case finding or ((active or passive) adj3 case finding)).ti,ab. 
46 
((program$ or scheme$1 or service$1 or campaign$ or mobili?ation or strateg$ or measure 
or policy or policies) and (tuberculosis or tb)).ti,ab. 
47 
((case adj3 management) or case-managed).ti,ab. or *case management/ or *patient care 
planning/ or *case management/ or exp *health care management/ 
48 (case adj3 manag$ adj3 strategy).ti,ab. or continuity of * patient care/ 
49 ((treat$ or diagnosis) and management).ti,ab. 
50 ((active or passive) and (Case adj3 Management)).ti,ab. 
51 (risk assess$ or risk profile or risk Indicator or care plan$).ti,ab. 
52 (service and (model$ or deliver$)).ti,ab. or delivery of * health care/ or *health service/ 
53 
((primary adj3 healthcare) or ((primary adj3 health$) or care)).ti,ab. or exp *primary health 
care/ 
54 
(nurse or ((general or family) adj3 (practice$ or practitioner$ or physicians$ or 
doctor$))).ti,ab. or exp *nurse/ or (exp *tuberculosis/ or (tuberculosis or tb).ti,ab.) or exp 
*general practice/ 
55 
((health or extension or multi-disciplinary or multidisciplinary) and (professional$ or 
personal$ or practitioner or worker$ or partner$ or promot$ or provider or care team or care 
provider or unit or casework$ or (case adj2 work$))).ti,ab. or *health care personnel/ or exp 
*nursing assistant/ 
56 (social adj2 (work$ or Support$ or Outreach)).ti,ab. or *social work/ or *social support/ 
57 
(volunteer$ or voluntary or charit$ or third sector).ti,ab. or *voluntary worker/ or exp 
*health care organization/ 
58 
(health adj1 (center$1 or centre$1 or facilit$ or service$ or clinic$1 or hospital$1 or 
program$1)).ti,ab. or *public health/ or *residential care/ 
59 ((day adj2 (care or hospital$ or patient$)) or workshop$).ti,ab. or *day care/ 
60 rehab$.ti,ab. or *rehabilitation center/ 
61 
((dedicated or permanent or rapid access or fixed or TB or tuberculosis) and (clinic$1 or 
centre$1 or center$1 or program$)).ti,ab. 
62 
(((drug adj2 dependency) or substance abuse or HIV) and (unit$ or clinic$1 or centre$1 or 
center$1 or program$) and (tuberculosis or tb)).ti,ab. 
63 (pharmac$ or dispensary).ti,ab. or *pharmacy/ 
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64 
(communit$ or (support$ adj2 communit$)).ti,ab. or *community care/ or *health auxiliary/ 
or *public relations/ or *community hospital/ or *community health nursing/ 
65 
(directly observed treatment or directly observed therapy or (supervised adj2 treatment) or 
(coerc$ adj2 (treat$ or therapy))).ti,ab. or Directly Observed Therapy/ 
66 (ambulatory adj2 care).ti,ab. or exp *ambulatory care/ 
67 
((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (health adj3 
(care or work$ or practitioner$ or professional$ or service$ or center$1 or centre$1 or 
unit$1 or program$))).ti,ab. or *preventive health service/ 
68 
((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (nurs$ or 
doctor$)).ti,ab. 
69 
((out adj3 hours) or (after adj3 hours) or telephone or telemedicine).ti,ab. or after-hours 
care/ or exp *telehealth/ or *emergency care/ or *health care delivery/ 
70 
((walk-in or walkin or walk in) adj2 (center$1 or centre$1 or service or program$ or 
Clinic$1 or Session or Assesment$1)).ti,ab. 
71 
(drop$ adj1 in adj2 (center$1 or centre$1 or service or program$ or clinic$1 or session or 
meeting or assesment$1)).ti,ab. 
72 
(((health or home$ or house$) and (call$ or visit$)) or (home-care or home-based or 
(support$ adj1 hous$))).ti,ab. or Home Health Aides/ or *health auxiliary/ or exp *home 
care/ 
73 
((early adj2 discharge) or (recent$ adj2 discharged) or (out adj2 patient)).ti,ab. or *patient 
care/ or *outpatient department/ 
74 
(counselling or counseling or counsellor or counselor or (integrated counselling adj1 testing 
centre$1) or (integrated counselling adj1 testing center$1) or ICTC).ti,ab. or *counseling/ or 
*directive counseling/ 
75 ((help adj2 group$) or (self adj2 help) or support$ or (peer adj2 peer)).ti,ab. or *self help/ 
76 
(collaborat$ or shared or (integrated adj1 care$) or ICP or network$ or co-locat$ or (one 
adj1 stop)).ti,ab. or *integrated health care system/ 
77 
((health adj2 education) or (skill adj2 mix) or (role adj2 develop$) or leadership or 
((interdisciplinary or inter-team or Professional or team) adj2 communicate$)).ti,ab. or exp 
*health education/ or exp *interdisciplinary communication/ or *leadership/ or *doctor 
patient relation/ or *nurse patient relationship/ or patient relationship*.ti,ab. 
78 
((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or pavement$1 
or sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium or sanitarium) and 
(tuberculosis or tb)).ti,ab. 
79 
((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or pavement$1 
or sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium or sanitarium) and 
(tuberculosis or tb)).ti,ab. 
80 or/40-79 
81 test$.ti,ab. 
82 (examination$1 or assessment$1 or identification or assay$ or detection).ti,ab. 
83 diagnosi$.ti,ab. or *diagnostic test/ 
84 ((chest adj2 x?ray) or chest radiograph or MXU).ti,ab. or *thorax radiography/ 
85 (screen$ or (new$ adj1 screen$)).ti,ab. 
86 (monitor$ or sampling).ti,ab. 
87 
((target$ or focus$ or community or population or individual$ or person$ or opportunistic or 
coerc$ or voluntary or initiated) and (test$ or diagnosis or screen$ or assay$ or 
detection)).ti,ab. 
88 PIT.ti,ab. 
89 provider initiated test$.ti,ab. 
90 
((rapid or prompt or quick$ or earl$ or (point adj2 care)) and (test$ or screen$ or diagnosi$ 
or assay$ or detection)).ti,ab. 
91 
((provider or anonymous or accurate or support$ or incentiv$ or counsel$) and (test$ or 
diagnosis or screen$ or assay$)).ti,ab. or *anonymous testing/ 
92 (test$ adj2 (center$1 or centre$1 or unit$1 or setting)).ti,ab. 
93 or/81-92 
94 
(acceptability or acceptable or attend$ or access$ or availab$ or non-attend$ or increas$ or 
promot$ or opt$ or particip$ or adhere$ or involvement or uptake or take-up or utiliz$ or 
utilis$ or refus$ or referr$ or self-referr$ or self-report$ or barrier$ or decreas$ or isolation 
or interven$ or aware$ or opportunit$ or advice or information or incentiv$ or recruit$ or 
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find or finding or compliance or comply or retain or retention or provision or encour$ or 
usage).ti,ab. 
95 
(socio sanitary support or reimburs$ or (social adj2 support) or ((cash or financial or money 
or monetary or economic or voucher or credit or drug$1 or methadone or telephone) adj2 
(benefit$ or support or incentive or assist$ or credit))).ti,ab. 
96 
(((lifestyle or behavio?r) adj2 (therapy or modif$ or chang$ or adapt$ or adopt$)) and 
(tuberculosis or tb)).ti,ab. or *social marketing/ 
97 *marketing/ 
98 *attitude to health/ 
99 *health care delivery/ 
100 *access to information/ 
101 *confidentiality/ 
102 *Health education/ 
103 *health promotion/ 
104 *patient compliance/ 
105 *motivation/ 
106 Stigma.ti,ab. 
107 *prevalence/ 
108 *patient participation/ 
109 *patient attitude/ or *refusal to participate/ or *treatment refusal/ 
110 or/94-109 
111 treat$.ti,ab. or Treatment Outcome/ 
112 
(directly observed treatment or directly observed therapy or (supervised adj2 treatment) or 
(coerc$ adj2 (treat$ or therapy))).ti,ab. or *directly observed therapy/ 
113 (disease management or (treat$ and (management or control))).ti,ab. 
114 
((adherence or compli$ or non-compli$ or default$ or finish$ or Retention or attrition or 
(drop adj1 out) or disappear$ or abscond$) and treat$).ti,ab. or exp *patient compliance/ 
115 ((referr$ or self-referr$ or (self adj diagnos$)) and treat$).ti,ab. 
116 ((suitab$ or eligib$) and treat$).ti,ab. 
117 ((follow adj1 up) or discharge).ti,ab. or *follow up/ 
118 ((positive or negative) and test).ti,ab. 
119 
((interrupt$ or relapse$ or stop$ or cessation or with?ld$ or avoidance or (lost adj2 follow)) 
and treat$).ti,ab. or *treatment withdrawal/ 
120 ((medicine$1 or drug or treat$) and (regimen or adherence)).ti,ab. or exp *self care/ 
121 (treat$ and (appointment$ or Schedule$)).ti,ab. or *patient scheduling/ 
122 ((care adj2 seeking) and pathway$).ti,ab. 
123 
((case adj3 management) or case-managed).ti,ab. or Case Management/ or *patient care 
planning/ or *health insurance/ 
124 
(case adj3 manag$ adj3 strategy).ti,ab. or continuity.mp. or *patient care/ [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
125 ((case or treat$ or diagnosis) and management).ti,ab. 
126 ((risk assessment or care plan$) and (case adj3 management)).ti,ab. 
127 ((active or passive) and (case adj3 management)).ti,ab. 
128 or/111-127 
129 1 and 39 and (80 or (93 and (110 or 128))) 
130 limit 129 to yr="1990 -Current" 
131 limit 130 to "english language" 
132 
(exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or 
humans).ti.) 
133 131 not 132 
134 limit 133 to yr="1990 - 2010" 
135 
(albania or bulgaria or cyprus or croatia or latvia or lithuania or luxembourg or malta or 
montenegro or romania or serbia or yugoslav or turkey).ti,ab,hw,in. 
136 1 and 135 and (80 or (93 and (110 or 128))) 
137 limit 136 to yr="1990 -Current" 
138 137 not 132 
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139 138 not 130 
140 133 not 134 
141 139 or 140 
 
 
2. Search in Embase Classic + Embase 1947 to 2014 December 2008 
Ovid 
Hits: 16,079 
 
1 exp *tuberculosis/ or (tuberculosis or tb).ti,ab. 
2 
((hard$ adj2 reach) or (hard$ adj2 locate) or (hard$ adj2 find) or (hard$ adj2 treat) or 
(difficult adj2 locate) or (difficult adj2 engage) or social$ exclu$ or social inequalit$ 
or (difficult$ adj2 reach) or (difficult$ adj2 find) or (difficult$ adj2 treat) or 
(christian* or church* or chapel* or priest* or vicar* or catholic* or catholicism or 
protestant* or methodist* or baptist* or Jehovah* or presbyterian* or anglican* or 
pentecostal*) or (muslim* or islam* or mosque* or imam*)).ti,ab. or exp *Jew/ or 
(jew* or judaism* or synagogue*).ti,ab. or exp *religion/ or (christian* or church* or 
chapel* or priest* or vicar* or catholic* or catholicism or protestant* or methodist* 
or baptist* or Jehovah* or presbyterian* or anglican* or pentecostal*).ti,ab. or (jew* 
or judaism* or synagogue*).ti,ab. or (sikh* or hindu* or buddhis* or temple*).ti,ab. 
or ((religion* or religious* or faith*) and (people* or person* or group* or 
population or neighbour* or neighbor* or patient* or communit*)).ti,ab. 
3 ((geograph$ or transport$ or physical) and barrier$).ti,ab. 
4 ((low$ or poor$ or negative) and (quality adj2 life)).ti,ab. 
5 
((vulnerable or disadvantaged or at risk or high risk or low socioeconomic status or 
neglect$ or affected or marginal$ or forgotten or non-associative or unengaged or 
hidden or excluded or transient or inaccessible or underserved or stigma$ or 
inequitable) and (people or population$ or communit$ or neighbourhood$1 or 
neighborhood$1 or group$ or area$1 or demograph$ or patient$ or social$)).ti,ab. or 
exp *vulnerable population/ 
6 *poverty/ 
7 
(refuser$1 or nonuser$1 or non-user$1 or non user$1 or discriminat$ or shame or 
prejud$ or racism or racial discriminat$).ti,ab. 
8 
*social support/ or exp *social status/ or *social stigma/ or exp *social isolation/ or 
exp *"quality of life"/ or exp *prejudice/ or exp *socioeconomics/ 
9 prisoner$1.ti,ab. 
10 
(recent$ adj2 release$ adj2 (inmate$ or prison$ or detainee$ or felon$ or offender$ or 
convict$ or custod$ or detention or incarcerat$ or correctional or jail$ or 
penitentiar$)).ti,ab. 
11 
((prison$ or penal or penitentiar$ or correctional facilit$ or jail$ or detention centre$ 
or detention center$) and (guard$1 or population or inmate$ or system$ or remand or 
detainee$ or felon$ or offender$1 or convict$ or abscond$)).ti,ab. 
12 (parole or probation).ti,ab. 
13 exp *prisoner/ 
14 
((custodial adj (care or sentence)) or (incarceration or incarcerated or 
imprisonment)).ti,ab. 
15 
(immobile or (disabled and (house bound or home bound)) or ((house or home) adj3 
bound)).ti,ab. or exp *homebound patient/ 
16 
((hous$ and (quality or damp$ or standard$ or afford$ or condition$ or dilapidat$)) or 
((emergency or temporary or inadequate or poor$ or overcrowd$ or over-crowd$ or 
over-subscribed) and (hous$ or accommodation or shelter$ or hostel$ or 
dwelling$))).ti,ab. or exp *housing/ 
17 
(rough sleep$ or runaway$1 or ((homeless$ or street or destitut$) and (population or 
person$1 or people or group$ or individual$1 or shelter$ or hostel$ or 
accommodation$1))).ti,ab. or exp *homelessness/ 
18 
((drug$ or substance) and (illegal or misus$ or abuse or intravenous or IV or problem 
use$ or illicit use$ or addict$ or dependen$ or dependant or delinquency)).ti,ab. or 
exp *addiction/ 
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19 
((alcohol$ and (misus$ or abuse or problem$ use$ or problem drink$ or illicit use$ or 
addict$ or dependen$ or delinquency)) or alcoholic$1).ti,ab. 
20 (prostitution or sex work$ or transactional sex$ or prostitute$1).ti,ab. or Prostitution/ 
21 (poverty or deprivation or financial hardship$).ti,ab. 
22 
((low-income or low income or low pay or low paid or poor or deprived or debt$ or 
arrear$) and (people or person$1 or population$1 or communit$ or group$ or social 
group$ or neighbourhood$1 or neighborhood$1 or famil$)).ti,ab. or exp *lowest 
income group/ 
23 *poverty/ 
24 (low$ and social class$).ti,ab. 
25 
(traveller$1 or gypsies or gypsy or Romany or roma).ti,ab. or exp *"Romani 
(people)"/ 
26 (mental$ and (health or ill or illness)).ti,ab. or *mental patient/ or exp *mental health/ 
27 
(health care worker$1 or (health care adj2 service provi$) or (health-care adj2 provi$) 
or (((community adj1 leader$) or (community adj1 (Manag$ or advocat$ or 
champion$))) and (engag$ or involv$))).ti,ab. 
28 (complex adj2 (patient$ or Need$)).ti,ab. 
29 (outreach adj2 worker$1).ti,ab. or exp *health auxiliary/ 
30 (support adj2 worker$1).ti,ab. 
31 (case adj2 worker$1).ti,ab. 
32 (social adj2 worker$1).ti,ab. 
33 social care professional$1.ti,ab. 
34 ((social care adj2 service provi$) or (social-care adj2 provi$)).ti,ab. 
35 
(((language$ or communicat$) and (barrier$ or understand$ or strateg$ or 
proficien$)) or translat$ or interpret$ or (cultur$ and competen$)).ti,ab. or *language 
ability/ 
36 
(immigrant$ or migrant$ or asylum or refugee$ or undocumented or foreign born or 
(born adj overseas) or (displaced and (people or person$1))).ti,ab. Or exp *refugee/ 
37 exp *migrant/ 
38 *immigration/  
39 or/2-38 
40 Intervention$.ti,ab. or exp *crisis intervention/ 
41 ((early or primary) adj2 Intervention$).ti,ab. 
42 
((person$ or individual or local$ or community or cultural or structural or supported 
or indicated or target$ or multi?component or comprehensive or pilot or media) and 
Intervention$).ti,ab. 
43 ((midstream or mid-stream) and intervention$).ti,ab. 
44 
(Identify$ or find or finding or locat$ or trac$ or contact$ or discover$ or detect or 
recruit$ or attract$).ti,ab. 
45 (case finding or ((active or passive) adj3 case finding)).ti,ab. 
46 
((program$ or scheme$1 or service$1 or campaign$ or mobili?ation or strateg$ or 
measure or policy or policies) and (tuberculosis or tb)).ti,ab. 
47 
((case adj3 management) or case-managed).ti,ab. or *case management/ or *patient 
care planning/ or *case management/ or exp *health care management/ 
48 (case adj3 manag$ adj3 strategy).ti,ab. or continuity of *patient care/ 
49 ((treat$ or diagnosis) and management).ti,ab. 
50 ((active or passive) and (Case adj3 Management)).ti,ab. 
51 (risk assess$ or risk profile or risk Indicator or care plan$).ti,ab. 
52 
(service and (model$ or deliver$)).ti,ab. or delivery of *health care/ or *health 
service/  
53 
((primary adj3 healthcare) or ((primary adj3 health$) or care)).ti,ab. or exp *primary 
health care/ 
54 
(nurse or ((general or family) adj3 (practice$ or practitioner$ or physicians$ or 
doctor$))).ti,ab. Or exp *nurse/ or (exp *tuberculosis/ or (tuberculosis or tb).ti,ab.)) 
or exp *general practice/  
55 
((health or extension or multi-disciplinary or multidisciplinary) and (professional$ or 
personal$ or practitioner or worker$ or partner$ or promot$ or provider or care team 
or care provider or unit or casework$ or (case adj2 work$))).ti,ab. or *health care 
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personnel/ or exp *nursing assistant/ 
56 
(social adj2 (work$ or Support$ or Outreach)).ti,ab. or *social work/ or *social 
support/ 
57 
((lay or allied or link) and (professional$ or practitioner$1 or worker$1 or advocate$1 
or personnel)).ti,ab. or *paramedical personnel// 
58 
(volunteer$ or voluntary or charit$ or third sector).ti,ab. or *voluntary worker/ or exp 
*health care organization/ 
59 
(health adj1 (center$1 or centre$1 or facilit$ or service$ or clinic$1 or hospital$1 or 
program$1)).ti,ab. or *public health/ or *residential care/ 
60 ((day adj2 (care or hospital$ or patient$)) or workshop$).ti,ab. or *day care/ 
61 rehab$.ti,ab. or *rehabilitation center/ 
62 
((dedicated or permanent or rapid access or fixed or TB or tuberculosis) and (clinic$1 
or centre$1 or center$1 or program$)).ti,ab. 
63 
(((drug adj2 dependency) or substance abuse or HIV) and (unit$ or clinic$1 or 
centre$1 or center$1 or program$) and (tuberculosis or tb)).ti,ab.  
64 (pharmac$ or dispensary).ti,ab. Or *pharmacy/  
65 
(communit$ or (support$ adj2 communit$)).ti,ab. or *community care/  or *health 
auxiliary/ or *public relations/ or *community hospital/ or *community health 
nursing/ 
66 
(directly observed treatment or directly observed therapy or (supervised adj2 
treatment) or (coerc$ adj2 (treat$ or therapy))).ti,ab. or Directly Observed Therapy/ 
67 (ambulatory adj2 care).ti,ab. or exp *ambulatory care/ 
68 
((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (health 
adj3 (care or work$ or practitioner$ or professional$ or service$ or center$1 or 
centre$1 or unit$1 or program$))).ti,ab. or *preventive health service/ 
69 
((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (nurs$ 
or doctor$)).ti,ab. 
70 
((out adj3 hours) or (after adj3 hours) or telephone or telemedicine).ti,ab. or after-
hours care/ or exp *telehealth/ or *emergency care/ or *health care delivery/ 
71 
((walk-in or walkin or walk in) adj2 (center$1 or centre$1 or service or program$ or 
Clinic$1 or Session or Assesment$1)).ti,ab. 
72 
(drop$ adj1 in adj2 (center$1 or centre$1 or service or program$ or clinic$1 or 
session or meeting or assesment$1)).ti,ab. 
73 
(((health or home$ or house$) and (call$ or visit$)) or (home-care or home-based or 
(support$ adj1 hous$))).ti,ab. or Home Health Aides/ or *health auxiliary/ or exp 
*home care/ 
74 
((early adj2 discharge) or (recent$ adj2 discharged) or (out adj2 patient)).ti,ab. or 
*patient care/ or *outpatient department/ 
75 
(counselling or counseling or counsellor or counselor or (integrated counselling adj1 
testing centre$1) or (integrated counselling adj1 testing center$1) or ICTC).ti,ab. or 
*counseling/ or *directive counseling/ 
76 
((help adj2 group$) or (self adj2 help) or support$ or (peer adj2 peer)).ti,ab. Or *self 
help/ 
77 
(collaborat$ or shared or (integrated adj1 care$) or ICP or network$ or co-locat$ or 
(one adj1 stop)).ti,ab. or  *integrated health care system/ 
78 
((health adj2 education) or (skill adj2 mix) or (role adj2 develop$) or leadership or 
((interdisciplinary or inter-team or Professional or team) adj2 communicate$)).ti,ab. 
or exp *health education/ or exp *interdisciplinary communication/ or *leadership/ or 
*doctor patient relation/ or *nurse patient relationship/  or patient relationship*.ti,ab. 
79 
((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or 
pavement$1 or sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium 
or sanitarium) and (tuberculosis or tb)).ti,ab. 
80 or/40-79 
81 test$.ti,ab. 
82 (examination$1 or assessment$1 or identification or assay$ or detection).ti,ab. 
83 diagnosi$.ti,ab. or *diagnostic test/ 
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84 ((chest adj2 x?ray) or chest radiograph or MXU).ti,ab. or *thorax radiography/ 
85 (screen$ or (new$ adj1 screen$)).ti,ab. 
86 (monitor$ or sampling).ti,ab. 
87 
((target$ or focus$ or community or population or individual$ or person$ or 
opportunistic or coerc$ or voluntary or initiated) and (test$ or diagnosis or screen$ or 
assay$ or detection)).ti,ab. 
88 PIT.ti,ab. 
89 provider initiated test$.ti,ab. 
90 
((rapid or prompt or quick$ or earl$ or (point adj2 care)) and (test$ or screen$ or 
diagnosi$ or assay$ or detection)).ti,ab. 
91 
((provider or anonymous or accurate or support$ or incentiv$ or counsel$) and (test$ 
or diagnosis or screen$ or assay$)).ti,ab. or *anonymous testing/ 
92 (test$ adj2 (center$1 or centre$1 or unit$1 or setting)).ti,ab. 
93 or/81-92 
94 
(acceptability or acceptable or attend$ or access$ or availab$ or non-attend$ or 
increas$ or promot$ or opt$ or particip$ or adhere$ or involvement or uptake or take-
up or utiliz$ or utilis$ or refus$ or referr$ or self-referr$ or self-report$ or barrier$ or 
decreas$ or isolation or interven$ or aware$ or opportunit$ or advice or information 
or incentiv$ or recruit$ or find or finding or compliance or comply or retain or 
retention or provision or encour$ or usage).ti,ab. 
95 
(socio sanitary support or reimburs$ or (social adj2 support) or ((cash or financial or 
money or monetary or economic or voucher or credit or drug$1 or methadone or 
telephone) adj2 (benefit$ or support or incentive or assist$ or credit))).ti,ab.  
96 
(((lifestyle or behavio?r) adj2 (therapy or modif$ or chang$ or adapt$ or adopt$)) and 
(tuberculosis or tb)).ti,ab. or *social marketing/ 
97 *marketing/ 
98 *attitude to health/ 
99 *health care delivery/ 
100 *access to information/ 
101 *confidentiality/ 
102 *Health education/ 
103 *health promotion/ 
104 *patient attitude/ or *refusal to participate/ or *treatment refusal// 
105 *patient compliance/ 
106 *motivation/ 
107 Stigma.ti,ab. 
108 *prevalence/ 
109 *patient participation/ 
110 or/94-109 
111 treat$.ti,ab. or Treatment Outcome/ 
112 
(directly observed treatment or directly observed therapy or (supervised adj2 
treatment) or (coerc$ adj2 (treat$ or therapy))).ti,ab. Or *directly observed therapy/ 
113 (disease management or (treat$ and (management or control))).ti,ab. 
114 
((adherence or compli$ or non-compli$ or default$ or finish$ or Retention or attrition 
or (drop adj1 out) or disappear$ or abscond$) and treat$).ti,ab. or exp *patient 
compliance/ 
115 ((referr$ or self-referr$ or (self adj diagnos$)) and treat$).ti,ab. 
116 ((suitab$ or eligib$) and treat$).ti,ab. 
117 ((follow adj1 up) or discharge).ti,ab. or *follow up/ 
118 ((positive or negative) and test).ti,ab. 
119 
((interrupt$ or relapse$ or stop$ or cessation or with?ld$ or avoidance or (lost adj2 
follow)) and treat$).ti,ab. or *treatment withdrawal/ 
120 ((medicine$1 or drug or treat$) and (regimen or adherence)).ti,ab. or exp *self care/ 
121 (treat$ and (appointment$ or Schedule$)).ti,ab. or *patient scheduling/ 
122 ((care adj2 seeking) and pathway$).ti,ab. 
123 
((case adj3 management) or case-managed).ti,ab. or Case Management/ or *patient 
care planning/ or *health insurance/ 
124 (case adj3 manag$ adj3 strategy).ti,ab. or continuity or *patient care/ 
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125 ((case or treat$ or diagnosis) and management).ti,ab. 
126 ((active or passive) and (case adj3 management)).ti,ab. 
127 ((risk assessment or care plan$) and (case adj3 management)).ti,ab. 
128 or/111-127 
129 1 and 39 and (80 or (93 and (110 or 128))) 
130 limit 129 to yr="1990 -Current" 
131 limit 130 to "english language" 
132 (animal$ or badger$ or Cow$ or Cattle or bovine).ti,ab. or (animals/ not humans/) 
133 131 not 132 
134 limit 133 to yr="1990 - 2010" 
135 130 not 132 
136 135 not 134 
137 
(albania or bulgaria or cyprus or croatia or latvia or lithuania or luxembourg or malta 
or montenegro or romania or serbia or yugoslav or turkey).ti,ab,hw,in. 
138 1 and 135 and (80 or (93 and (110 or 128))) 
139 limit 138 to yr="1990 -Current" 
140 139 not 132 
141 140 not 135 
142 136 or 141 
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Supplementary Material IV: Evidence Statements 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tuberculosis identification 
 
Evidence statement 1: Effectiveness of using different types of healthcare workers on 
improving identification of active TB 
1·1 Conflicting evidence arose concerning types of healthcare workers to improve TB 
screening. Aldridge et al., 2015 [+] showed that the uptake of TB screening did not improve 
when peers encourage and educate homeless people, compared to shelter personnel.1 On the 
contrary, Duarte et al. 2011 [-]2 and Goetsch et al. 2012 [-]3 showed an increase in uptake of TB 
screening amongst homeless people and drug users after involving community health workers 
(CHW) and key partners in the education and promotion of TB screening. The results 
demonstrated by Goetsch et al. fluctuated over the study period and both studies retrospectively 
compared the findings over different time periods, which might be an important source of bias.  
 
1·2 Moderate evidence from two studies focussing on the identification of TB contacts by using peers. 
One study identified by this review, Ospina et al. 2012 [+], showed that contact tracing among 
migrants improved significantly by using CHWs from the same migrant community to coordinate 
contact tracing.4 The comparison group was recruited over a different time period, which reduced the 
quality of this study.  
Ricks, 2008 [++],5 identified by the NICE review,6 suggested that contact tracing of drug users with 
active TB improved by using former drug users compared to healthcare workers. It was unclear if the 
improvement could be contributed to the use of peers, as the study also used enhanced case 
management for the peer-led intervention group, the control group received limited case management. 
 
Evidence statement 2: Effectiveness of using different settings on improving identification of 
active TB  
2·1 Weak evidence from Jit et al. 2011 [+] showed that a mobile TB service is an effective 
intervention to identify hard-to-reach individuals with TB as 35% of the cases identified by this mobile 
Grading of evidence 
 
No evidence – no evidence or clear conclusions from any of the studies; 
Weak evidence – no clear or strong evidence/conclusions from high quality studies and only tentative 
evidence/conclusions from moderate quality studies or clear evidence/conclusions from low quality 
studies; 
Moderate evidence – tentative evidence/conclusions from multiple high quality studies, or clear 
evidence/conclusions from one high quality study or multiple medium quality studies, with minimal 
inconsistencies across all studies;  
Strong evidence – clear conclusions from multiple high quality studies. 
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TB service were asymptomatic.7 
 
Four studies were identified by the NICE review,6 providing the following evidence: 
2·2 Weak evidence from Mor et al., 2008 [-] suggesting that pre-migration screening in Ethiopian 
migrants reduced the risk of developing active TB in Israel and reduced the time from entry into the 
host country (Israel) until TB diagnosis compared to post-migration screening.8 The study compared 
two migrant groups recruited over two different time period what limited the quality of the findings. 
 
2·3 Weak evidence from El-Hamad et al., 2001 [+] suggesting that active case finding conducted in a 
TB clinic improved TB screening completion among migrants compared to TB screening conducted in 
a non-specialist primary care facility.9 However, the study did not adjust for the differences in baseline 
characteristics. 
 
2·4 Weak evidence from Bothamley et al., 2002 [-] showing that TB screening by symptom-based 
questionnaire was less useful in port-of-arrival clinics compared to homeless centres.10 In 90.9% of the 
migrants screened by questionnaire further TB screening was conducted compared to 100% of the 
questionnaire screened homeless people. The study findings were limited as the study compared two 
different hard-to-reach groups in two different settings.  
 
2·5 Weak evidence from Miller et al., 2006 [+] suggesting that there was no significant statistical 
difference in screening uptake in the homeless centre where screening was optional and a prison where 
screening was mandatory, however, the homeless people received incentives for TB screening.11 In the 
homeless centre more cases were detected but different methods were used. The evidence was weak as 
the study compared two groups with possibly different baseline characteristics, different TB prevalence 
and different tests were offered.  
 
Evidence statement 3: Cost-effectiveness of using different settings on improving identification of 
active TB 
3·1 Weak evidence from Jit et al. 2011 [+] that a mobile TB service is cost-effective, the incremental 
cost ratio for the screening service was £18,000 per Quality of Life Year (QALY) gained.7 
 
A further two studies were identified by the NICE review:6  
3·2 Weak evidence from Mor et al., 2008 [-] suggesting that pre-migration screening in Ethiopian 
migrants would save Israel $449,817 over a five year period.8 Different sources were used for the cost 
analysis, with varying reliability, limiting the findings.  
 
3·3 Weak evidence from Bothamley et al., 2002 [-] showed that TB screening among migrants as part 
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of the port-of-arrival programme had a cost-saving of £12.70 per person screened, it would costs an 
additional £0.50 per person screened at a homeless centre and £7.00 per migrant screened at a general 
practice.10 The findings of this study are limited as the study compared two different populations with 
possible different characteristics and TB prevalence. 
 
Tuberculosis management 
 
Evidence statement 4: Effectiveness of using different types of healthcare workers on improving 
management of active TB 
Moderate evidence from one study identified by the NICE review6, Ricks, 2008 [++], suggested that 
drug users receiving enhanced case management by peers were more likely to complete TB treatment 
than drug users who received limited case management by healthcare workers (RR = 2.68, 95%CI 
1.24-5.82; p = 0.01).5 The findings of this study are limited as the intervention group received 
enhanced case management and were managed by peers, therefore it is unclear which of the two 
contributed (more) to the improved treatment outcome.   
 
Evidence statement 5: Effectiveness of using different settings on improving management of 
active TB 
5·1 Weak evidence from Jit et al. 2011 [+] that treatment completion rate in patients treated by the 
mobile ‘Find and Treat’ service was higher (67.1%)  than in the patients receiving standard care at a 
TB clinic (56.8%) and lost to follow-up rate in the patients treated by the mobile ‘Find and Treat’ 
service was lower (2.1%) than in the patients receiving standard care at a TB clinic (17.2%).7 
 
5·2 Weak evidence from Deruaz & Zellweger, 2004 [-], showed that there was no statistical difference 
in treatment outcome when directly observed treatment was delivered at the healthcare facility or at a 
convenient site in the community in mixed hard-to-reach groups.12 The findings were limited by a 
potential selection bias and the way the treatment outcome was collected differed in both groups.  
 
Evidence statement 6: Cost-effectiveness of using different settings on improving management of 
active TB 
6·1 Weak evidence from Jit et al. 2011 [+] that a mobile TB management service is cost-effective, the 
incremental cost ratio for the service was £4,100 per Quality of Life Year (QALY) gained.7 
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Supplementary Material V: Data extraction forms  
 
 
Study details Population and 
setting 
Method of 
allocation to 
intervention/ 
control 
Outcomes and 
methods of analysis 
Results Note by review team 
Year: 
2015 
 
Country: 
United Kingdom 
(UK) 
 
Authors: 
Aldridge R.W., 
Hayward A.C., 
Hemming S. et al.1 
 
Citation: 
Aldridge R.W., 
Hayward A.C., 
Hemming S. et al. 
Effectiveness of peer 
educators on the 
uptake of mobile X-
ray tuberculosis 
screening at 
homeless hostels: a 
cluster randomised 
controlled trial. BMJ 
open 2015; 5: 
e008050. 
 
Aim of study: 
Source 
population(s): 
Homeless people 
Eligible population: 
Hostels for homeless 
people in London, 
UK 
 
Selected population: 
Homeless people at 
hostels in London, 
UK 
 
All hostels in London 
who participated in 2 
previous screening 
sessions were eligible 
for inclusion. 
Eligible hostels had 
not been screened in 
the 6 months prior to 
the scheduled mobile 
X-ray Unit (MXU) 
screening session. 
 
Excluded 
population: 
Method of 
allocation: 
Sites were 
randomized to 
intervention or 
control group by 
Sealed EnvelopeTM 
http://www.sealeden
velope.com/) which 
ensured allocation 
concealment until 
interventions were 
assigned. To ensure 
comparability 
between intervention 
and control arms, 
hostels were 
stratified on the basis 
of their size (binary 
variable indicating 
whether hostels had 
more than 43 beds) 
and previous 
screening uptake 
level (binary variable 
indicating whether 
hostels had greater 
than 50% historical 
Primary outcomes: 
The number of 
eligible clients at a 
hostel venue 
screened for active 
pulmonary 
tuberculosis by MXU 
 
Secondary 
outcomes: 
Secondary analysis 
was also conducted 
by subgroups, for 
large and small 
hostels separately, 
and low and high 
previous screening 
uptake level using 
the binary categorical 
variables described 
previously for these 
analyses. 
 
Method of analysis: 
The study statistician 
conducted analysis 
blinded to the 
allocation of 
Primary results: 
Control sites: 
- 1,192 residents 
- Median uptake of 45% 
(inter-quartile range 
(IQR):33,55) 
 
Intervention sites:  
-1,150 eligible residents   
- Median uptake of 40% 
(IQR:25,61) 
 
Poisson regression to 
account for the 
clustered study design, 
hostel size and 
historical screening 
levels, there was no 
evidence that peer 
educators increased 
uptake (adjusted risk 
ratio 0.98; 95% 
confidence interval 
(95%CI): 0.80,1.20). 
 
Secondary results: 
No evidence was found 
for peer educators 
Limitations identified 
by author: 
- The study design was 
not powered to detect a 
difference in 
tuberculosis cases 
identified by the two 
arms as this would 
require considerably 
larger sample sizes and 
would have meant 
repeated screening at 
hostels, potentially 
diluting the effect of 
the intervention during 
the study 
- Unable to collect 
individual data as part 
of the study as this 
would have required 
individual consent and 
would have been 
challenging logistically 
given that screening 
took place within an 
operational setting 
where any data 
collection would have 
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To compare current 
practice for 
encouraging 
homeless people to 
be screened for 
tuberculosis by a 
mobile digital X-ray 
unit in London, UK, 
with the additional 
use of volunteer peer 
educators who have 
direct experience of 
tuberculosis and 
homelessness. 
 
Study design: 
Cluster randomised 
controlled trial 
 
Quality score: 
+ 
 
Applicability: 
++ 
- Hostels with uptake 
levels over 80% were 
excluded from the 
study – as low 
chance of 
intervention having 
impact 
- Not allowing peers 
on the venue 
 
Setting: 
Homeless hostels in 
London, UK 
 
Sample 
characteristics: 
Majority of hostels 
had 43 or less beds, 
reported a historical 
screening uptake of 
>50% and provided 
no incentives for 
screening. 
uptake).  
 
A cluster randomised 
design was chosen as 
the intervention was 
aimed at the hostel 
sites rather than 
individuals clients 
 
Intervention(s) 
description: 
Peers moved around 
the hostel in 
conjunction with 
hostel staff and spoke 
to residents in order 
to encourage them to 
attend screening. 
 
Comparator/ 
control(s) 
description: 
Encouragement by 
hostel staff 
 
Baseline 
comparisons: 
Proportion of people 
screened for TB 
Study sufficiently 
powered?: 
Yes, power 
calculation done 
before hand, met the 
sample size 
intervention or 
control arms. 
 
Poisson regression 
analysis was used to 
analyse outcome 
events at screening 
hostels. Bed 
occupancy level was 
included as the 
exposure variable, 
screening uptake as 
the outcome (or 
indicator) variable, 
and hostel venue as a 
random effect to 
account for clustering 
at each site. The 
analysis was adjusted 
by inclusion of the 
randomisation 
stratification factors 
of historical uptake 
rates and bed size. 
 
Modelling method 
and assumptions: 
Clustered analysis, 
assuming that 
characteristics of the 
populations at 
respective hostels 
were comparable. 
Time horizon: 
February 2012 and 
increasing uptake of 
screening for any of the 
other secondary 
analyses. The study 
team noted no adverse 
events. 
 
 
interrupted the flow of 
screening and caused 
unacceptable delays for 
service users 
- Peers may lack 
technical knowledge 
and the confidence 
with which to 
challenge some of the 
client misconceptions 
and concerns that 
reduce screening 
uptake 
- Most effective when 
complemented i.e. 
delivered in 
conjunction with 
professionals 
 
Limitations identified 
by review team: 
- Hostels with high 
uptake were excluded = 
bias risk 
- Most sites were not 
naïve to peer 
intervention 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Any difference in 
uptake with previous 
screening sessions? 
 
- Effectiveness of using 
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requirement of 1045 
individuals, or 
approximately 21 
hostels in each arm 
 
October 2013 peers as a standalone 
intervention versus 
peers working 
alongside professionals 
and this remains an 
important research 
question. 
 
Source of funding: 
NIHR and Welcome 
Trust. 
Conflict of interests: 
None for most authors 
- AS (last author) is 
clinical lead for the 
Find and Treat service 
including the mobile 
digital X-ray unit. 
 
Study details Population and 
setting 
Method of 
allocation to 
intervention/ 
control 
Outcomes and 
methods of analysis 
Results Note by review team 
Year: 
2012 
 
Country: 
Germany 
(Frankfurt/Main) 
 
Authors: 
Goetsch U., Bellinger 
O.K., Buettel K.L., 
Gottschalk R.2   
Source 
population(s): 
Homeless & drug 
users  
Eligible population: 
Homeless & drug 
users recruited from 
homeless and drug 
services in 
Frankfurt/Main 
Method of 
allocation: 
Not applicable (NA) 
 
Intervention(s) 
description: 
Community health 
worker educated staff 
and users of services 
for homeless and 
drug users about TB 
Primary outcomes: 
Feasibility and 
sustainability of a TB 
programme focussing 
on TB education and 
voluntary X-ray 
investigation in 
homeless and drug 
users 
 
Secondary 
Primary results: 
It is feasible when 
included in already 
existing public health 
services 
 
Secondary results: 
- No. CXR: 10/month in 
homeless & 9/month in 
drug users 
After intervention 
Limitations identified 
by author: 
- Selection bias, illegal 
immigrants might 
avoid authorities 
- Small number of TB 
patients makes it 
difficult to say 
anything about age and 
gender differences 
- No data on length of 
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Citation: 
Goetsch U., Bellinger 
O.K., Buettel K.L., 
Gottschalk R.   
Tuberculosis among 
drug users and 
homeless persons: 
impact of voluntary 
X-ray investigation 
on active case 
finding. Infection 
2012; 40: 389-95. 
 
Aim of study: 
To evaluate the  
feasibility and 
sustainability of the 
program, its coverage 
and both the case-
finding rates and 
characteristics of 
cases. Also to assess 
the treatment 
outcomes 
 
Study design: 
Before and after 
comparison 
 
Quality score: 
- 
 
Applicability: 
+ 
 
Selected population: 
All subjects seen at 
the Public Health 
Department for chest 
X-rays (CXR) and 
fulfilling the criteria 
for homeless (stayed 
at shelter for >2 
nights) /drug users 
(attend day-care 
facilities, night 
shelter for drug users 
or needle exchange 
programme)  
 
Excluded 
population: 
Patients with 
tuberculosis  (TB) 
symptoms detected in 
clinics and notified 
through the 
Protection against 
Infection Act 
 
Setting: 
Community health 
worker (CHW) went 
to services to 
promote CXR 
– CXR performed at 
Public Health 
Department 
 
Sample 
transmission and 
promoted voluntary 
CXR at Public 
Health Department 
1x/year or at least 
1x/2years 
 
Community Health 
Worker obtained the 
medical history 
through standardised 
questionnaire 
 
CXR read by TB 
physician – referral 
and follow up test in 
a clinic could be 
initiated immediately 
 
Suspicion for active 
TB – CHW took care 
of further diagnostics 
and follow up 
Active TB needed 
hospitalisation for 
treatment 
 
CHW kept contact 
with doctors/social 
workers 2x/month, 
later monthly 
Contact tracing in 
shelter 
 
HIV was only 
notified in active TB 
outcomes: 
Estimate the 
coverage of the 
programme, assess 
other risk factors and 
determine TB rates & 
treatment outcome in 
the 2 groups 
 
Method of analysis: 
- t-test or analysis of 
variance for 
continuous variables 
- chi-square test or 
Fisher’s exact test for 
categorical data 
 
Modelling method 
and assumptions: 
- Multivariate logistic 
regression effect of 
risk groups, birth 
place, age & gender  
Time horizon: 
1 May 2002 – 
30 April 2007 
46/month in homeless 
& 25/month in drug 
users 
 
Coverage:  
- Screening 1x/2 years: 
18% of drug users & 
26% of homeless  
- Screening every year: 
10% of drug users & 
15% of homeless (based 
on the range of drug 
users & homeless 
people between 6,416 
and 9,000 individuals in 
Frankfurt/Main) 
- Chao’s heterogeneity 
model: 18-26.3%  
1 CXR/2 years  
   - 2002-2004: 18.0%  
   - 2003-2005: 19.3%  
   - 2004-2006: 26.4%  
   - 2005-2007: 23.4%  
and 10-15%  CXR/year   
   - 2002-2004: 10.0%   
   - 2003-2005: 10.7%  
   - 2004-2006: 15.0%  
   - 2005-2007: 23.4% 
 
Case finding: 
- 39 TB cases in 5 
years: 14 drug users & 
25 homeless 
= 8.7% of total TB 
cases in Frankfurt 
- 19 cases smear +, 7 
drug use and 
homelessness 
- The impact of HIV 
can’t be estimated 
- Unknown fluctuations 
of the study population 
make the denominator 
unstable 
 
Limitations identified 
by review team: 
- Patients had to travel 
to the public health 
department 
- Comparison over 
time, important 
confounder 
- Not adjusted for 
distance from service 
to public health 
department 
 
Evidence gaps and/or 
recommendations for 
future research: 
Use a control group 
and use of mobile CXR 
unit to increase 
screening uptake 
 
 
Source of funding: 
Not recorded (NR) 
Conflict of interests: 
None 
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characteristics: 
4,529 CXRs in 3,477 
people 
- 66% homeless 
- 34% drug users 
 
Homeless: 
- 40.9 years ± 12.5 
years 
- 90.1% male 
- 29.6% foreign born 
 
Drug users: 
- 35.8 years ± 8.3 
years 
- 76.2% male 
- 28.0% foreign born 
(increased over study 
period  2002: 15%, 
2007:37%) 
 
patients 
 
Comparator/ 
control(s) 
description: 
Before intervention – 
no CHW who gave 
TB education and 
promoted CXR 
 
Baseline 
comparisons: 
Coverage of CXR 
screening before and 
after intervention 
Study sufficiently 
powered?:  
Low number of 
active TB cases 
smear –ve but culture 
+ve 
- 13 cases clinical/ 
radiological diagnosis 
- Case finding rate 
861/100 000 CXRs 
- Drug users 10/14 HIV 
+ve, homeless 1/25 HIV 
+ve (p<0.001) 
 
No significant 
difference in case-
finding rates according 
to gender (906/100,000 
for men vs. 601/100,000 
for women; p = 0.43), 
place of origin 
(906/100,000 for 
natives vs. 752/100,000 
for foreign born; p = 
0.61) or between the 
risk groups 
(888/100,000 for the 
homeless vs. illegal 
drug users (816/ 
100,000; p = 0.80). 
 
Logistic regression 
model with the risk 
factors age, gender, risk 
group and place of 
origin: age was the only 
variable to be associated 
with the risk of TB and 
the variable risk group 
was an effect modifier 
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Treatment completion 
- 76.3% (29/38) 
completed treatment 
(one patient left 
Frankfurt to unknown 
destination before 
completion of 
treatment, excluded 
from analysis of 
treatment completion) – 
of which 19 homeless 
people and 10 drug 
users  
- 5 people needed 
admission because of 
non-compliance (3 drug 
users, 2 homeless) 
- 5 people died of other 
causes than TB (3 
homeless and 2 drug 
users) 
- 4 people stopped 
treatment (lack of 
compliance) – 10.5% 
 
No difference in the 
treatment outcome 
between the two risk 
groups (p = 0.96), and 
age, gender or HIV-
status did not have any 
significant effect on 
treatment outcome. 
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Study details Population and 
setting 
Method of 
allocation to 
intervention/ 
control 
Outcomes and 
methods of analysis 
Results Note by review team 
Year: 
2012 
 
Country: 
Spain, Barcelona 
 
Authors: 
Ospina J.E., Orcau 
A., Millet J-P. et al.3 
 
Citation: 
Ospina J.E., Orcau 
A., Millet J-P. et al. 
Community health 
workers improve 
contact tracing 
among immigrants 
with tuberculosis in 
Barcelona. BMC 
public health 2012; 
12: 158. 
 
Aim of study: 
To evaluate the 
effectiveness of an 
intervention with 
CHW to improve 
contact tracing 
among immigrants 
 
Study design: 
Source 
population(s): 
Migrants 
Eligible population: 
Migrants in 
Barcelona 
 
Selected population: 
All TB cases 
registered by the 
TBPCP (the 
Barcelona TB 
Control Program) 
between January 1st 
2000 and December 
31st 2005, and 
resident in the city of 
Barcelona were 
included 
 
Excluded 
population: 
Not registered TB 
patients 
 
Setting: 
Barcelona TB 
program  
 
Sample 
Method of 
allocation: 
All TB cases 
registered at TBPCP 
 
Intervention(s) 
description: 
Community health 
workers (CHW) 
actively follow up 
the cases and 
contacts, visit the 
cases at home, 
accompany case to 
outpatient 
appointments, 
provide counselling 
and information on 
treatments. 
Educational sessions 
in health care centres, 
private homes and 
immigrant 
associations. 
Assistance with 
obtaining residence 
permits, housing, 
food banks, public 
dining halls and 
health card 
application.  
Primary outcomes: 
The influence on 
contact tracing of  
CHW intervention 
 
Secondary 
outcomes: 
The influence on 
contact tracing of 
other variables:  sex, 
age, hospital of 
diagnosis, district of 
residence, birthplace, 
HIV, homeless 
 
Method of analysis: 
- Descriptive analysis 
was performed by 
calculating 
proportions 
- The median and 
interquartile range 
were calculated for 
quantitative variables 
- Categorical 
variables were 
compared using the 
X2 test. Odds ratio 
(OR) and 95%CI were 
calculated as a 
measure of 
Primary results: 
- The increase in 
contact tracing 
coverage of contacts of 
smear positive PTB 
and all clinical forms 
of TB in the 
intervention period was 
statistically significant 
* 81% (post) vs 65.7% 
(pre)  
*OR = 1.6 (95%CI = 
1.2-2.0)  
* Adjusted OR 1.8 
(95%CI: 1.3-2.5)  
p < 0.001 
 
-  CHW intervention 
had an aOR of 2.4 
(95%CI: 1.3-4.3) 
p=0.005 to fail contact 
tracing for smear-
positive cases and an 
aOR of 1.8 (95%CI: 
1.3-2.5); p = 0.001 for 
all TB cases 
 
Secondary results: 
- Factors associated 
with failure to conduct 
contact tracing for 
Limitations identified 
by author: 
- Variation in 
characteristics between 
both periods; an 
increase of cases 
between 25-39 years of 
age, from Latin 
America and India, 
Pakistan and from 
inner-city in the CHW 
group. The increase in 
immigrants would most 
likely have worsened 
contact tracing and 
therefore our figures 
may have 
underestimated the 
benefit of the CHW 
intervention. 
 
Limitations identified 
by review team: 
- Wide 95% CI’s smear 
+ve making the OR 
less precise for: 
* Hospital D 
* Area of origin 
* District of residence 
unknown 
*HIV +ve 
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Quasi-experimental 
study with historical 
pre-post comparison 
 
Quality score: 
+ 
 
Applicability: 
++ 
characteristics: 
572 cases pre-
intervention & 388 
post-intervention 
  
Pre-intervention 
- 202 (35.3%) were 
from Latin American 
countries 
-136 (23.8%) from 
India or Pakistan  
- 92 (16.1%) from 
North Africa 
- 142 cases (24.8%) 
from other countries 
 
- Majority men 
- 25-39 years 
- 72.2% Pulmonary 
TB 
- 35.3% smear +ve 
- 34.4% lived in 
inner city 
 
Post intervention 
- 152 (39.2%) were 
from Latin American 
countries 
- 112 (28.9%) from 
India or Pakistan  
- 42 (10.8%) from 
North Africa 
- 16 (4.1%) from 
Sub-Saharan Africa 
- 66 cases (17%) 
from other countries 
 
Comparator/ 
control(s) 
description: 
Pre-intervention 
 
Baseline 
comparisons: 
Pre- /post- 
intervention contact 
tracing was 
compared  
 
Study sufficiently 
powered? 
Yes; 95% CI 
sufficiently narrow 
association. 
 
Modelling method 
and assumptions: 
Stepwise backward 
logistic regression; 
variables lacking 
significant association 
measures in univariate 
analysis were 
assumed not to be 
confounders. 
Time horizon: 
1st 2000 and 
December 31st 2005 
smear +ve TB include: 
 * Diagnosed in 
hospitals B and D   
* Birthplace in India-
Pakistan  
or North Africa  
* Unknown district of 
residence  
* HIV infection  
* Homeless  
 
- Factors associated 
with failure to conduct 
contact tracing for all 
forms of TB include: 
* Male  
* Hospitals B and D  
* Birthplace other than 
Latin American 
countries 
* Unknown district of 
residence  
* Incarceration history  
* Homeless  
* Index wh  had 
culture-negative or 
extra-pulmonary TB or 
had a normal chest X-
ray 
 
- Of all TB cases 
identified among 
foreign born people, 
79.4% were seen by 
CHWs, 12.4% were 
contacted directly by 
* Homeless 
 
- Wide 95% CI’s all 
TB: making the OR 
less precise for: 
* District of residence 
unknown 
* Incarceration 
* Homeless 
 
95% CI’s crossing 1 in 
hospital D 
 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Studies on cost-
effectiveness of the 
CHW interventions in 
the TB programs  
 
 
Source of funding: 
NR 
Conflict of interests: 
None 
Page 76 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
9 
 
 
- Majority men 
- 25-39 years 
- 73.2% Pulmonary 
TB  
- 39.2% smear +ve 
- Almost 50% lived 
in inner city 
the public health nurse 
and the remaining 
8.2% could not be 
contacted 
- Active follow up in 
194 TB cases and 
contact census, a total 
of 293 counselling 
sessions, 147 linguistic 
mediation session, 264 
individualised and 97 
group educational 
sessions about TB, 280 
home visits, 70 hospital 
visits and 5,935 
telephone calls (a 
median of 15.3 calls 
per case) were 
performed 
 
 
Study details Population and 
setting 
Method of 
allocation to 
intervention/ 
control 
Outcomes and 
methods of analysis 
Results Note by review team 
Year: 
2011 
 
Country: 
Portugal 
 
Authors: 
Duarte R., Santos A., 
Mota M. et al.4  
 
Source 
population(s): 
Drug users in Vila 
Nova de Gaia, 
Portugal 
 
Eligible 
population: 
Drug users in Vila 
Nova de Gaia 
Method of 
allocation: 
Before and after 
2004 – intervention 
was implemented in 
2004 
 
Intervention(s) 
description: 
After 2004: 
Primary outcomes: 
Diagnosis of active 
TB, treatment 
compliance before 
and after intervention 
 
Secondary 
outcomes: 
OR and 95%CI to 
measure association 
Primary results: 
2001-2003: 
- 125 drug users 
observed in CDP of 
which: 
* 52 drug users were 
screened for TB (100% 
male, mean age 32 
years) 
* 73 drug users were 
Limitations identified 
by author: 
- Not a controlled trial  
- Risk for bias 
- Unknown what part 
of the intervention 
contributed to the 
outcome 
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Citation: 
Duarte R., Santos A., 
Mota M. et al. 
Involving community 
partners in the 
management of 
tuberculosis among 
drug users. Public 
Health 2011; 125: 
60-2. 
 
Aim of study: 
To evaluate the effect 
of the intervention on 
diagnosis of TB and 
treatment compliance 
 
 
Study design: 
Retrospective review 
of records 
Comparison before 
and after intervention 
(2004) 
 
Quality score: 
- 
 
Applicability: 
+ 
(VNdG), Portugal 
 
Population VNdG: 
290,000 
 
Estimated number of 
drug users = 4.3-6.4 
per 1,000 inhabitants 
 
Selected population: 
Screening and 
treatment records for 
all drug users visiting 
Chest Disease Centre 
(CDP) between 
2001-2007 
 
Excluded 
population: 
NR 
 
Setting: 
All drug users 
screened and treated 
at the outpatient TB 
clinic (Chest Disease 
Centre) 2001-2007 
were reviewed 
 
Sample 
characteristics: 
2001-2003: 
- 125 drug users 
@CDP  
- 52 screened (100% 
Intervention to 
improve early 
identification and 
treatment of drug 
users with TB. 
 
The key partners 
(outpatient TB clinic, 
drug users support 
centres, shelters and 
street teams, local 
public health 
department and the 
local hospital) 
identified drug users 
in their population 
- Promotion of 
health-seeking 
behaviour  
- Notification card 
for screening in CDP 
- Elimination of 
potential barriers: 
* Street teams 
offered free transport 
*All care at CDP free 
of charge  
- Encouraged referral 
but tried to manage 
TB screening locally  
- Seriously ill: 
immediate referral to 
CDP/local hospital 
(with transport and 
attendance) 
 
 
Method of analysis: 
OR and 95%CI were 
used to measure the 
strength of the 
association 
 
Modelling method 
and assumptions: 
Improve early 
identification and 
treatment of drug 
users with TB 
Time horizon: 
2001-2003 
Intervention 
2005-2007 
referred to CDP because 
of symptoms or 
following discharge 
from hospital with 
diagnosis TB 
 
Of all drug users 
observed at CDP; 82 
drug users (65.6%) were 
diagnosed with active 
TB of which 11 drug 
users  (13.4%) were 
identified by screening 
 
Treatment compliance: 
- 47.6% poor 
compliance 
- 35.4% stopped TB 
treatment 
 
TB in VNdG 2001-
2003:  
- 515 TB cases of which 
82 were drug users 
- 32 TB cases died of 
which 15 were drug 
users (OR 4.66, 95%CI 
2.24 - 9.70). 
- TB/HIV co-infection: 
63 (71%) 
 
2005-2007: (after 
implementation of the 
programme)  
- 465 drug users were 
screened for TB (86% 
Limitations identified 
by review team: 
- Retrospective design 
= risk of bias 
- Methods not well 
described 
- Unknown what 
percentage did not 
come for screening 
(how many people 
recruited for screening) 
- Difference in time 
zone = risk for 
confounders, might 
have been on the 
political agenda, been 
on the news etc. = bias 
- Low precision of 
estimates of effects 
(indicated by wide 
95%CI) probably due 
to small sample size 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Case-control trial to 
compare 2 different 
cities (one with 
intervention other 
without intervention 
- Check cost-
effectiveness 
 
 
Source of funding: 
Page 78 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
11 
 
male, mean age 32 
years) 
- 73 for symptoms or 
following discharge 
with diagnosis TB 
 
2005-2007: 
- 465 screened (86% 
male, mean age 36 
years) 
- 30 for symptoms or 
following discharge 
with diagnosis TB 
 
Study definitions: 
Active TB: culture 
M. tuberculosis or 
clinical & radiology 
criteria 
Latent TB:  
asymptomatic 
individuals with 
normal chest 
radiography and 
positive TST (TST > 
5 mm in immune-
compromised 
persons, TST > 10 
mm in immune-
competent 
persons) 
 
At CDP: 
- Screening: 
symptom 
questionnaire, 
tuberculin skin test 
(TST) & CXR: 
annual 
screening/after 
contact/symptoms 
- Directly observed 
therapy short-course 
(DOTS) at CDP, 
combined with other 
medical treatment/ 
drug abuse treatment 
- CDP offered HIV 
testing in case of 
active TB 
 
Comparator/ 
control(s) 
description: 
Before 2004:  
- Drug users referred 
to CDP with a 
diagnosis of TB after 
diagnosis from 
hospital  
– Treatment was not 
compulsory 
– To improve 
compliance: info was 
provided, 
psychosocial support, 
full treatment to 
patient and family (if 
male, mean age 36 
years) 
- 30 drug users were 
referred to CDP because 
of symptoms or 
following discharge 
from hospital with 
diagnosis TB 
 
Of all drug users seen at 
the CDP, 59 drug users 
(11.9%) were diagnosed 
with active TB of which 
36 drug users (61%) 
were identified by 
screening 
 
Treatment compliance: 
- 23.7% poor 
compliance 
- 10.2% stopped 
treatment 
 
TB in VNdG 2005-
2007:  
- 386 TB cases of which 
59 were drug users 
- 19 TB cases died of 
which 8 were drug users  
(OR 4.66, 95%CI 1.79 - 
12.15) 
- TB/HIV co-infection: 
37 (64%) 
 
Conclusion:  
The number of screened 
None 
 
Conflict of interests: 
None 
 
Ethical approval: 
Yes, approved by the 
CDP de Vila Nova de 
Gaia body 
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needed), transport & 
free breakfast.  
- No active screening 
policy 
 
Baseline 
comparisons: 
Number of TB cases 
screened 
Study sufficiently 
powered: 
NR but wide 95%CI 
drug users had 
increased, therapy was 
available to a higher 
proportion of TB cases 
and active TB treatment 
compliance had 
improved significantly  
 
Secondary results: 
- Drug users screened 
for TB without 
symptoms: OR 21.8; 
95%CI 13.0-36.3 
- Drug users with active 
TB: OR 10.1; 95%CI 
4.44-23.0 
- Poor compliance: 
OR 0.34; 95%CI 0.16-
0.72 
- Treatment stopped 
OR 0.21; 95%CI 0.08-
0.54 
- % of drug users under 
TB cases OR 0.95; 
95%CI 0.66-1.37 
 
- Mortality due to TB 
decreased from 18.3% 
in 2001- 2003 to 13.6% 
in 2005-2007 among 
drug users (OR 0.7, 
95%CI 0.28 - 1.78). 
 
- TB/HIV co-infection 
decreased from 63 
(71%) in 2001-2003 to 
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37 (64%) in 2005-2007 
(OR 1.37, 95%CI 0.68-
2.78). 
 
 
Study details Population and 
setting 
Intervention/compa
rator 
Outcomes and 
methods of analysis 
 
Results Note by review team 
Year: 
2011 
 
Country: 
UK 
 
Authors: 
Jit M. Stagg H.R., 
Aldridge R. et al.5 
 
Citation: 
Jit M. Stagg H.R., 
Aldridge R. et al. 
Dedicated outreach 
service for hard to 
reach patients with 
tuberculosis in 
London: 
observational study 
and economic 
evaluation. BMJ 
2011; 343: d5376. 
 
Aim of study: 
To assess the cost 
effectiveness of the 
Find and Treat 
Source 
population(s): 
Hard-to-reach 
individuals 
 
Eligible population: 
Hard-to-reach 
individuals with 
active pulmonary 
tuberculosis 
 
Selected population: 
Hard to reach 
individuals with 
active pulmonary 
tuberculosis screened 
or managed by the 
Find and Treat 
service 
 
Excluded 
population: 
- Cases with extra-
pulmonary 
tuberculosis 
- Latent tuberculosis 
- Suspected 
Method of 
allocation: 
NA 
 
Intervention(s) 
description: 
All individuals are 
screened on 
voluntary basis.  
1. Mobile X-ray 
screening clinic 
visited locations 
where high-risk 
groups could be 
found (homeless 
shelters, drug 
treatment centres, 
criminal services, 
street outreach etc.) 
2. Raise awareness 
3. Under take case 
holding 
4. Provide support 
for treatment 
completion 
(supported by peer 
workers) 
Primary outcomes: 
Incremental costs, 
quality adjusted life 
year (QALY), for the 
Find and Treat 
service. 
 
Secondary 
outcomes: 
Cost-effectiveness 
ratios for the Find 
and Treat service 
 
Method of analysis: 
NR 
 
Modelling method 
and assumptions: 
- Discrete, multiple 
age cohort, 
compartmental 
model to model a 
population of 
individuals with 
active tuberculosis 
 
4 groups: 
Primary results: 
The model estimated 
that, on average, the 
Find and Treat service 
identifies 16 and 
manages 123 active 
cases of tuberculosis 
each year in hard to 
reach groups in London. 
The service has a net 
cost of £1.4 million/year 
and, under conservative 
assumptions, gains 220 
QALYs. The 
incremental cost 
effectiveness ratio was 
£6,400-£10,000/QALY 
gained (about €7300-
€11,000 or $10,000-
$16,000 in September 
2011).  
 
- 22.9% of patients 
detected by the mobile 
screening unit with the 
longest delays between 
symptom onset and 
Limitations identified 
by author: 
- Absence of 
randomisation of 
tuberculosis cases to be 
either managed or not 
managed by the Find 
and Treat service 
-  The service also 
manages extremely 
hard to reach 
individuals, who are 
often already lost to 
follow-up at the time of 
referral or who would 
never present for care 
without the mobile 
screening unit. Hence 
the comparison of 
cases with 
retrospective controls 
probably 
underestimates the 
incremental benefit of 
the service, although 
we cannot be certain 
without a randomised 
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service for 
diagnosing and 
managing hard to 
reach individuals 
with active 
tuberculosis in 
London 
 
Study design: 
Economic evaluation 
using a discrete, 
multiple age cohort, 
compartmental 
model of treated and 
untreated cases of 
active tuberculosis. 
 
Type of economic 
analysis: 
Cost-effectiveness 
 
Economic 
perspective: 
Healthcare taxpayer 
perspective 
 
Internal validity: 
Yes 
 
Quality score: 
++ 
 
Applicability: 
+ 
tuberculosis 
- Cases merely 
receiving prophylaxis 
(and hence unlikely 
to have active 
tuberculosis) 
- Cases for which the 
diagnostic delay 
could not be 
calculated 
- Cases younger than 
16 years 
 
Setting: 
London, United 
Kingdom. 
 
Sample 
characteristics: 
- 48 mobile screening 
unit cases 
- 188 cases referred 
for case management 
support 
- 180 cases referred 
for loss to follow-up 
- 252 control cases, 
TB cases that 
presented to a TB 
clinic themselves, 
without intervention 
of the Find and Treat 
service (current 
method of passive 
case finding) 
 
 
Comparator/ 
control(s) 
description: 
Controls: passively 
detected cases with 
active pulmonary 
tuberculosis 
(individuals who 
presented to London 
tuberculosis services 
on their own accord 
without screening 
and referral to the 
Find and Treat 
service - notified to 
the Health Protection 
Agency’s enhanced 
tuberculosis 
surveillance system 
between 1 January 
2009 (when the 
system began 
recording risk factor 
information) and 9 
August 2010. 
Controls were age 
matched with 
actively detected 
cases (within five 
year age categories) 
and had to display 
one or more risk 
factors (a history of 
homelessness or 
imprisonment, drug 
- Active untreated 
tuberculosis 
- Active treated 
tuberculosis with 
up to 125 days of 
continuous treatment 
- Active treated 
tuberculosis with 
more than 125 days 
of continuous 
treatment 
- Lost to follow-up 
 
4 final outcomes:  
- Completion of 
treatment 
- Death due to 
tuberculosis related 
causes 
- Death due to other 
causes 
- Other final 
outcomes that the 
Find and Treat 
service is not 
expected to change 
(such as patients 
being transferred out 
of London or 
stopping treatment 
for clinical reasons). 
 
Assumptions: 
- The cost of a new 
mobile unit £600,000 
were added to the 
treatment presentation 
were unlikely to present 
for treatment without 
the activities of the Find 
and Treat service 
-  35.4% of mobile 
screening unit patients 
were asymptomatic on 
detection, and hence 
would not have 
presented for treatment 
without the unit. 
-  Once on treatment, 
mobile screening unit 
cases managed by the 
Find and Treat service 
had a much lower risk 
of loss to follow-up than 
passively presenting 
controls (loss to follow-
up probability after one 
year: 2.1% for cases, 
17.2% for controls) 
- Cases referred to Find 
and Treat because of 
complex case 
management issues had 
higher rates of 
completing treatment 
(61.2% after one year) 
and lower rates of loss 
to follow-up (3.3% after 
one year) than controls 
 
Secondary results: 
-  Every year the service 
study 
- Did not incorporate 
secondary transmission 
into the economic 
evaluation, even 
though the mobile 
screening unit in 
particular probably 
averts several 
secondary cases by 
finding highly 
infectious individuals. 
- Did not measure the 
effect of the Find and 
Treat service on 
reducing the likelihood 
of patients developing 
and transmitting 
acquired drug 
resistance (as a result 
of poor treatment 
adherence). Drug 
resistance increases the 
duration and costs of 
treatment, as well as 
the risk of severe 
disease, thus 
prevention could be an 
important benefit 
 of the service. 
Limitations identified 
by review team: 
Small group of PTB in 
intervention group 
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Economic analysis 
data source: 
Find and Treat 
database for 
information 
(including risk factors 
and clinical 
information) of 
individuals, 
diagnosed with PTB 
(between Sep 2007- 
Sep 2010) 
 
The control group 
(TB cases that 
presented on their 
own accord to a TB 
clinic) was obtained 
from the Health 
Protection Agency 
between Jan 2009 
and Aug 2010. 
Risk factors and 
clinical information 
for the controls were 
obtained from the 
enhanced 
tuberculosis 
surveillance system. 
or alcohol abuse, or 
mental 
health problems). 
 
Baseline 
comparisons: 
Compared:   
- Having no Find and 
Treat service, 
- Having only one 
part of the service 
(the mobile screening 
unit or the cas  
management 
component) 
- Having both parts 
of the service 
 
Study sufficiently 
powered: 
NR but a small 
number of PTB cases 
in the Find and Treat 
group 
costs of the first year 
of the service, with 
discounted costs and 
outcomes totalled 
over five years 
- Costs of 
£8,300 and £75,000 
for treatment of DS-
TB and MDR-TB 
- Only 50% of 
asymptomatic cases 
with a positive result 
from the mobile 
screening unit would 
progress to 
symptomatic disease 
- Find and Treat 
cases would be lost 
to follow-up at the 
same rate as 
enhanced 
tuberculosis 
surveillance controls 
(17.2% per year) in 
the absence of the 
service, rather than at 
the higher rate we 
estimated for this 
extremely hard to 
reach group (34.7% 
per year). 
- Even without Find 
and Treat 
involvement, these 
cases could still 
passively re-engage 
has a net cost of £1.4 
million and gained 220 
QALYs 
-  Incremental cost 
effectiveness of the 
Find and Treat service 
was £6,400/QALY 
gained 
- Both components of 
the service are cost-
effective at the same 
threshold. The mobile 
screening unit had an 
incremental ratio of 
£18,000/QALY gained, 
whereas the case 
management component 
had an incremental ratio 
of £4,100/QALY gained 
(In the most 
unfavourable (and 
highly unlikely) 
scenario, which 
combined all the 
unfavourable 
assumptions, the mobile 
screening unit and case 
management 
components had 
incremental ratios of 
£26,000/QALY gained 
and £6,800/QALY 
gained, respectively) 
 
0.5% of mobile 
screening unit patients 
Evidence gaps and/or 
recommendations for 
future research: 
Include a larger 
intervention group, 
longer follow up study 
Source of funding: 
Grant from the English 
Department of Health 
grant reference number 
0150305 
 
PJW was partly funded 
by centre funding from 
the Medical Research 
Council. IA and HS are 
partly funded by the 
National Institute for 
Health 
Research. 
 
Conflict of interests: 
None 
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with treatment at the 
same rate as 
enhanced 
tuberculosis 
surveillance controls 
(51% per year). 
 
Time horizon: 
Sep 2007 – July 2010 
and 5.3% of other Find 
and Treat patients had 
multidrug or extensively 
drug resistant infection 
 
List of Abbreviations 
aOR = adjusted Odds Ratio; CDP = Chest Disease Centre; CHW = Community Health Worker; CXR = Chest X-Ray; HIV = Human Immunodeficiency Virus; IQR = Inter-
Quartile Range; MXU = Mobile X-ray Unit; NA = Not Applicable; NIHR = National Institute for Health Research; NR = Not Recorded; OR = Odds Ratio; p = p-value; PTB 
= Pulmonary Tuberculosis; QALY = Quality Adjusted Life Year; TB = Tuberculosis; TBTCP = The Barcelona TB Control Program; TST = Tuberculin Skin Test; UK = 
United Kingdom; VNdG = Vila Nova de Gaia; 95%CI = 95% Confidence Interval 
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Supplementary Material VI: Quality Assessment 
 
Quality assessment of included effectiveness studies 
                   Questions about:        Population                      Method of selection                                 Outcomes                                                    Analysis                               Summary 
Year First author (year) 1·1 1·2 1·3 2·1 2·2 2·3 2·4 2·5 3·1 3·2 3·3 3·4 3·5 4·1 4·2 4·3 4·4 5·1 5·2 Score 
 Studies identified for this review 
2011 Duarte et al.5  ++ + - NA + ++ - ++ + + - + ++ NA + - + - - - 
2012 Goetsch et al.20  ++ + - NA + ++ - ++ ++ - - NA NA NR ++ - - - - - 
2012 Ospina et al.21  ++ ++ ++ ++ ++ ++ - ++ + ++ - NA NA ++ ++ - ++ - ++ + 
2015 Aldridge et al.19  ++ ++ ++ ++ ++ - - ++ + ++ + NA NA - + + + + + + 
 Studies identified for the NICE review12 
2001 El-Hamad et al.24  ++ + ++ NA ++ ++ + + ++ ++ + ++ ++ NR ++ + ++ + + + 
2004 Deruaz & 
Zellweger28  
++ + + - + - - + - ++ ++ ++ ++ NR - ++ + - + - 
2008 Ricks23 ++ + ++ ++ ++ ++ ++ + + ++ ++ ++ + NR ++ ++ ++ ++ + ++ 
 
 
 
 
  
++ well designed study, minimal risk of bias 
+ study may not have addressed all potential sources of bias 
-  significant risk of bias 
NA not applicable 
NR not reported 
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Quality assessment questions for effectiveness studies: 
1·1  Is the source population or source area well described? 
1·2  Is the eligible population or area representative of the source population or area? 
1·3  Do the selected participants or areas represent the eligible population or area? 
2·1  Selection of exposure (and comparison) group. How was selection bias minimised? 
2·2  Was the selection of explanatory variables based on a sound theoretical basis? 
2·3  Was the contamination acceptably low? 
2·4  How well were likely confounding factors identified and controlled? 
2·5  Is the setting applicable to Europe? 
3·1  Were the outcome measures and procedures reliable? 
3·2  Were the outcome measurements complete? 
3·3  Were all the important outcomes assessed? 
3·4  Was there a similar follow-up time in exposure and comparison groups? 
3·5  Was follow-up time meaningful? 
4·1  Was the study sufficiently powered to detect an intervention effect (if one exists)? 
4·2  Were multiple explanatory variables considered in the analyses? 
4·3  Were the analytical methods appropriate? 
4·4  Was the precision of association given or calculable? Is association meaningful? 
5·1  Are the study results internally valid (i.e. unbiased)? 
5·2  Are the findings generalisable to the source population (i.e. externally valid)? 
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Quality assessment of included cost-effectiveness studies 
 Questions about:      Applicability                                                                                   Study limitations 
Year First author  1·1 1·2 1·3 1·4 1·5 1·6 1·7 1·8 2·1 2·2 2·3 2·4 2·5 2·6 2·7 2·8 2·9 2·10 2·11 Overall 
 Studies identified for this review 
2011 Jit et al.21  
 
Y Y Y Y N N Y N Y Y N Y Y Y Y Y Y Y N Potential serious 
limitations [+] 
 Studies identified for the NICE review12 
2002 Bothamley et al.25  PA Y Y N PA N N PA PA U/C PA N N Y N N Y PA N Very serious 
limitations [-] 
2006 Miller et al.26  Y Y PA N PA N N PA PA PA PA PA PA PA PA PA Y Y N Potential serious 
limitations [+] 
2008 Mor et al.27  PA Y PA N PA N N PA PA PA PA N PA PA U/C U/C Y N N Very serious 
limitations [-] 
 
 
 
 
 
 
 
  
Y Yes to question 
N No to question 
PA Partially applicable 
NA Not Applicable 
U/C Unclear 
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4 
 
Quality assessment questions for cost-effectiveness studies:  
1·1 Is the study population appropriate for the topic being evaluated? 
1·2 Are the interventions appropriate for the topic being evaluated? 
1·3 Is the system in which the study was conducted sufficiently similar to the current European context? 
1·4 Was/were the perspective(s) clearly stated and what were they? 
1·5 Are all direct health effects on individuals included, and are all other effects included where they are material? 
1·6 Are all future costs and outcomes discounted appropriately? 
1·7 Is the value of health effects expressed in terms of quality-adjusted life years (QALYs)? 
1·8 Are costs and outcomes from other sectors fully and appropriately measured and valued? 
2·1 Does the model structure adequately reflect the nature of the topic under evaluation? 
2·2 Is the time horizon sufficiently long to reflect all important differences in costs and outcomes? 
2·3 Are all important and relevant outcomes included? 
2·4 Are the estimates of baseline outcomes from the best available source? 
2·5 Are the estimates of relative 'treatment' effects from the best available source? 
2·6 Are all important and relevant costs included? 
2·7 Are the estimates of resource use from the best available source? 
2·8 Are the unit costs of resources from the best available source? 
2·9 Is an appropriate incremental analysis presented or can it be calculated from the data? 
2·10 Are all important parameters whose values are uncertain subjected to appropriate sensitivity analysis? 
2·11 Is there any potential conflict of interest? 
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PRISMA 2009 Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
3 and 
Supp Mat 
II 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
3 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
4 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
4 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Sup mat 
III 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
4 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
4 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
4 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
5 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  5 
Page 89 of 90
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
PRISMA 2009 Checklist 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I
2
) for each meta-analysis.  
5 
 
Page 1 of 2  
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
- 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
- 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
5 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Table 1, 
page 17 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Sup mat 
VI and 
page 6, 7 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
6, 7 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  - 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Sup mat 
VI 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  -  
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
8 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
8 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  9 
FUNDING   
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PRISMA 2009 Checklist 
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
12 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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